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Case study of patient with Multiple Sclerosis disease  
 
Thesis aim and clinical findings  
This thesis involves a case study approach for a patient with Multible Sclerosis. The thesis 
is divided into theoretical part which describes the background of Multiple Sclerosis . 
The other part is special part, which contains all the work I have done with my patient, 
all the examinations, conclusions, therapies and results. 
 
Methods 
The practical part took a place in Oblastní nemocnice Kladno, it is based on a female 
patient, who is suffering from Multiple sclerosis, The patient had one session every day 
during these two weeks I was there. In total the patient had 5 sessions with me. All the 
methods applied are from what we have learn and practice during my study in the 
faculty of physical education and sport, and also all the methods were non-invasive 
 
Result 
After the therapy sessions my patient had a slight progress. Range of motion was 
increased, strength was improved, The therapies have shown to be effective concerning 
my patient’s diagnosis 
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1 MULTIPLE SCLEROSIS 
1. Introduction 
 
This disease has been reported to affect individuals who are mostly 20 years 
to 40 years old. From the name itself, it is evident that multiple sclerosis refers to 
multiple scarring or destruction of the white matter of the spinal cord and brain. 
These defects can severely affect ones’ quality of life. There is still no known cure 
for these diseases; however, few comprehensive treatments have been suggested to 
delay the progression of the disease.  Bearing the definitions of physical activity 
and exercise in mind and by considering its effectiveness in improving the physical 
fitness of normal individuals and also having the potential to improve the disabilities 
in the patients living with MS, it is now clear that physiotherapy is the most effective 
way to help the patients living with MS to recover from their sufferings due to this 
disease. 
 Thus, here in my Bachelor Thesis, I have chosen this disease not only due to 
its unfortunate widespread and timeliness but also because the of experience that I 
was gaining due to my surroundings i.e., witnessing a number of cases of MS.  Thus, 
I will be discussing a case study of physiotherapy treatment of  my patients who 
was diagnosed with Multiple Sclerosis, which I performed under the supervision of 
an experience physiotherapist from the Department of physiotherapy Bc. Tomas 
Modlinger in Oblastní nemocnice Kladno during my clinical work placement. 
During this therapy of my patient, I will be using different physiotherapy strategies, 
I will not be using any kind of invasive techniques.  
My patient was a female with a height of 161 cm, weigh of 85 Kgs, BMI of 
32.8 with normal cognitive abilities. When I first met her prior to the initiation of 
her treatment she was dependent on the roll aid walker and ankle foot orthosis on 
her right side. With a hope and faith on the physiotherapy strategies my main 
purpose in this case study would be to plan and implement effective 
physiotherapeutic techniques on my patient so that at the end of her treatment 
regimen she is able to perform all her activities independently and without the need 
of any supportive devices. The aim of this rehabilitation will be improve the overall 
condition and slow the progression of the disease. 
Therefore, I will be dividing this thesis into two parts: theoretical and 
practical. In the theoretical part, I will be describing the effects of multiple sclerosis, 
it pathophysiology, etiology, prognosis, treatment available and other latest 
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available information of multiple sclerosis. Following this, for the practical part, I 
will be discussing different physiotherapeutic procedures that I will be choosing to 
treat my patient and finally conclude on the effectiveness of my service to her and 



























3 MULTIPLE SCLEROSIS 




     Multiple sclerosis (MS) is one of the leading causes of neurological disability 
among the young adult population in all industrialised countries (Compston and 
Coles, 2008; Myhr et al., 2001). It is chronic neurological disabilities that occur in 
the central nervous system and there has been no identified cure yet reported. It 
results in damaged central nervous system, which presents a number of symptoms 
that might affects ones’ sensory, motor and autonomic systems in those who are 
affected by this disability (Compston and Coles, 2008).  
       The Northern Europe along with Norway are the high- risk areas, where the 
approximately 5 to 8 individual per 1,00,000 people are affected and the prevalence 
is 150 to 170 individuals per 1,00,000 people (Myhr, 2010; Alstadhaug, Olavsen, & 
Salvesen, 2005). The disease results in wide range of symptoms that affects ones’ 
ability to independently perform his/ her daily activities (ADL); of which the 
disturbances in movement is one of the major issues. Research has shown that 
rehabilitation interventions such as physical activity and exercise are most 
beneficial for the management of symptoms of this disease and other associated 
disabilities in individuals who are victims of MS (National Institute for Clinical 
Excellence (NICE), 2004). Thus, for such patients, physiotherapy is popular and is 
recommended widely (European Multiple Sclerosis Platform [EMSP], 2012; 
National clinical guideline for diagnosis and management in primary and secondary 
care [NICE], 2004) and is commonly used by people with MS (PwMS) (K. Gottberg 
et al., 2008; Skovgaard et al., 2012). These two rehabilitative interventions have 
been shown by various researchers to aid the strength, mobility, cardiovascular 
fitness, quality of life and endurance (Snook and Motl, 2009; Motl et al., 2008b; 
Rietberg et al., 2004; Petajan et al., 1996).  
             Optimising partaking in the ADL through body functions improvement and 
activities as per the International Classification of Health and Disability 1 (ICF) 
(World Health Organization [WHO], 2001) are some of the main targets of 
physiotherapy for patients living with MS in combination with the information and 
support to self- manage their condition throughout the disease course (Multiple 
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Sclerosis Society [MSS], 2004; NICE, 2004). The health cares for people living 
with MS are personified by concurrent long- time use of healthcare services in 
different healthcare organization and communities (K. Gottberg et al., 2008; Helse 
Nord, 2007). However, irrespective of the known benefits that are associated with 
physical inactivity and exercise, patients living with MS are still considered to be 
inactive (Sandroff et al., 2012; Moti, McAuley, and Snook, 2005), which can pose 
them to greater risks of acquiring secondary health complications that are associated 
with inactivity (Moti and Goldman, 2011) such as Type 2 Diabtes, Stroke, and 
Cardiovascular disorders (Motl, McAuley and Snook, 2005; Stuifbergen and 
Roberts, 1997). 
 Inactivity is not explicit to patients living with MS, but is an expression of 
the activities of the general population all across the world (Lee et al., 2012). The 
Government in UK has initiated a wide range of schemes in order to address the 
rising problem of inactivity such as Start Active and Stay Active, Exercise Referral 
Scheme, etc. (Department of Health (DOH), 2001;DOH, 2011). However, these 
schemes specifically targeted the healthy population and could not provide any clear 
evidence about the efficacy of these physical activity and exercise for individuals 
who live with chronic disabling conditions. Researchers suggest that in order to 
promote increased physical activity and exercise among patients living with MS, it 
is essential to include “Blue Prescription”, “Behavioural approaches” and “Self- 
Management programmes” in the treatment regimen (Barlow et al., 2009b; Plow et 
al., 2009., McAullet et al., 2007). Blue Prescription is a physiotherapy approach that 
is designed to promote patients with MS to adhere to regular exercise and increase 
their physical activity (Mulligan et al., 2013; Smith et al., 2013a; Hale et al., 2012). 
However, the above- mentioned studies have demonstrated a very limited impact 
on the increase in exercise and physical activity in patients living with MS. 
Likewise, other studies have also assessed and investigated the facilitators and 
barriers of physical activity and exercise in the MS patients (Asano et al., 2013; 
Kayes et al., 2011a); however, there is still very limited studies present that provides 
in- depth understanding on the process of translation of these into increased exercise 
and physical activity.  
Physical activity refers to any movement in the body that is produced by the 
skeletal muscles, which results in loss of energy (Caspersen, Powell and 
Christenson, 1985 p.126) and would include occupational, sports and domestic- 
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related activities. While on the other hand, exercise if referred as a subset of planned 
physical activity that is not only structured but is also repetitive (Caspersen, Powell 
and Christenson, 1985 p.126) and its objective is to either maintain or improve one’s 
physical fitness. Every health professionals plays a major role in promoting both 
physical activity and exercise. Thus, the role of a physiotherapist is very important 
as they play a key role in establishing newer and effective ways to help patients with 
their disabilities and promote increased physical activity and exercise (World 
Confederation for Physical Therapy (WCPT), 2014; Chartered Society of 
Physiotherapy (CSP), 2011). However, there is a very little guidance and 
understanding for physiotherapists when managing patients living with MS with 
respect to physical activity and exercise in the community. The recent guidelines 
from the National Institute of Health and Care Excellence (NICE, 2014) 
recommends the inclusion of physical activity and exercise in the management 
strategies for MS. However, its centre of attention on exercise is very narrow and 
thus there is an urgent need to re-evaluate the physical activity component that is a 
much broader in scale and integrates exercise as an important component to manage 
the issues in the MS patients in the community. 
In different European countries, physiotherapy has been recommended for 
patients living with MS by the community physiotherapists (cPTs) (Norsk 
fysioterapeut forbund [NFF], 2012a). The traditional in- patient care has been 
substituted with treatment in out- patient (OP) clinics, in which most treatments 
(NICE, 2004; Solari et al., 2007) are provided as multidisciplinary services. Some 
clinics also provide more systematic follow- up of physiotherapy that starts after the 
diagnosis and continues throughout the disease course and thus only single sessions 
are provided on a regular basis that are again complemented by the professional 
guidance from community physiotherapists. 
Based on the needs for information of the patients living with MS and their 
follow- ups with respect to movement disturbances and collaborations among the 
different levels of healthcare to secure the quality and continuity of care, it is 
convenient to understand the gain of the MS patients from these single sessions of 
physiotherapy in the clinics ((EMSP, 2012; Guthrie, Saultz, Freeman, & Haggerty, 
2008; Haggerty et al., 2003; Helse- og omsorgstjenesteloven, 2011; Helse Nord, 
2007; NFF, 2012a). Moreover, the lack of competencies of the neurological 
physiotherapy among the community physiotherapists, the responsibility of the 
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hospitals for providing guidance to the healthcare workers and an international 
focus on Continue Professional Development (CPD) raises the concern for further 
investigation on the impact of professional guidance to the community 
physiotherapists in these clinics might entail for the ones who are undergoing this 
service ((Helse- og omsorgstjenesteloven, 2011; Helse-og omsorgsdepartementet 
[HOD], 2011; French & Dowds, 2008; NFF, 2012b).  
 
2.2.  Background of Multiple Sclerosis 
 
 Multiple Sclerosis (MS) is a chronic neurological disability disorder in which 
results in the demyelinating condition of the Central Nervous System (CNS) of the 
patients (Steadman, 2012; Compston and Coles, 2008). It is firmly believed by 
experts that multiple sclerosis is mainly characterized by an inflammatory process 
that results in demyelination (gradual deterioration of the myelin sheath) 
surrounding the axons in the Central Nervous System, thereby, ultimately resulting 
in the loss of axons (Compston and Coles, 2008). This process is believed to occur 
over a period of time and is substantiated by the presence of scars or sclerotic 
plaques along the myelin sheath thereby causing the interruption in the conductivity 
of electrical impulses along those fibres that are usually used to transfer information 
or messages between the spinal cord and the brain (Steadman, 2012; Compston and 
Coles, 2008). This disruption of the electric impulses that occurs as a result of 
inflammatory processes and degeneration of axons are responsible for the well- 
known clinical features observed in individuals who are victims of Multiple 
Sclerosis (Compston and Coles, 2008; Ambler, 2011).      
  This disease is considered one of the chronic diseases among the autoimmune 
disorders and its exact pathogenesis is yet undetermined. A number of research 
studies are still being conducted at present and researchers are yet to present a clear 
view on its pathogenesis. So far, there are lack of much effective therapies to treat 
this disorder in patients and completely cure them; however, the available 
therapeutic options such as certain pharmacological drugs, and physiotherapy 
allows the healthcare professionals to plan timely and appropriate intervention for 
patients to help them lead a good quality of life (Mares, 2012). 
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2.3. Epidemiology  
 
 Multiple Sclerosis is a very common yet very complex neurological disorder. 
Approximately 2.5 million individuals in the world are living with this condition 
while 4,00,000 patients were reported to suffer from this disease in Europe itself 
(Figure 1) (Flachenecker and Stuke, 2008; Mackenzie et al., 2014).  
The prevalence rates varies from > 100 to 200 cases/ 1,00,000 in North America 
to <5 cases/ 1,00,000 in the South America and Asian regions. While in Australia, the 
rates vary between 11 to 74 cases/ 1,00,000. It usually affects individuals aged 15 to 75 
years and the peak onset age is 20 - 40 years (Compston et al., 1998). Mackenzie (2014) 
have demonstrated in their study that the 5- year difference in the MS peak incidence rate 
to be between women – 40 years and men – 45 years. Men has been reported to be 
diagnosed much later in years and they tend to suffer from more aggressive pattern of 
this disorder (Koch-Henriksen and Sørensen, 2010; Compston and Coles, 2002). 
Usually, the women are more susceptible to develop this disease than men 
and their ratio is 3.2 : 1 while the ration between girls to boys living with this disease 
is 3:1. This could be because of the difference in the sexes; however, there are no 
Figure 1 worldwide prevalence of multiple sclerosis 
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studies being conducted in this area. The incidence of this disease is uneven all 
across the world. These differences in its incidence are strictly attributed to different 
geographical locations, culture and ethnicity (Havrdová 2009; Scolding, Wilkins, 
2012).  
This disease has been found to be mostly diagnosed among the Indo- 
European race; especially in individuals who have Scandinavian origin are at higher 
risk of developing this disorder. In Asia, a special version of multiple sclerosis has 
been reported to occur, which is commonly known as neuromyelitis optica 
(Havrdova, 2009; Scolding and Wilkins, 2012). In Czech Republic, the prevalence 
of this disease has been reported to range from 17,000 to 20,000 individuals who 
are predominantly are of working age (Horakova, 2011). Even though it is a non- 
genetic disease, yet there are evidences that 20% of the patients have one or two 
cases of MS running in their families (Kalib, 2012). 
However, the general life span of this patients living with Multiple Sclerosis 
is similar to that of the general population (Perry, 1994); however, a recent study 
proved that these patients might have a lower life- span of 5- 10 years than the 
normal individuals (Hurwitz, 2011). Since the disease mostly affects during the 
working years of an individual, thus, their social physical and economic 
implications are huge. 
 
2.4. Etiology of Multiple Sclerosis 
 
The cause of this disease is yet to be determined and it is usually said that it 
occurs as a result of complex interactions between environmental factors and 
susceptibility genes. The two common environmental factors that have been said to 
be involved in the disease pathogenesis are viral infection i.e., Epstein- Barr virus 
and lack of exposure to sunlight. A number of research groups have been trying to 
decipher the actual etiology behind the disease; however, yet not has been 
discovered; however, they believe that it occurs due to a number of factors that are 
associated with it. The studies are under process in the field of epidemiology, 
immunology, and genetics. Additionally, the infectious agents that might play a 
crucial role in its development are also being investigated. Understanding the exact 
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etiology of this disease will help researchers to speed up the process of identifying 
more effective ways to treat this disease and either prevent its occurrence or totally 
cure it. 
So in summary, Multiple sclerosis (MS) is a neurodegenerative disease of 
uncertain etiology. In MS, neurodegeneration is thought to be secondary to 
autoimmune-mediated damage. However, no cohesive explanation yet exists as to 
how environmental factors interact to induce a neurodegenerative autoimmune 
response. Insufficient sunlight exposure and chronic viral infections have been 
proposed as unrelated environmental risk factors for MS. We suggest that these risk 
factors may act synergistically to enable the pathogenic autoimmune response. Low 
ultraviolet light (UVL) exposure depletes vitamin D3 stores, and low vitamin D3 
levels correlate strongly with high MS risk. The central nervous system converts 
vitamin D3 into 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3), a biologically active 
hormone with anti-inflammatory and neuro-protective functions that depend on IL-10-
producing regulatory lymphocytes. Herpesvirus infection also correlates with MS risk. 
Some herpesviruses like Epstein-Barr virus produce an IL-10-like cytokine termed 
vIL-10. We hypothesize that vIL-10 may induce a dysfunction of IL-10-producing 
regulatory lymphocytes, thereby undermining the protective functions of sunlight, 
vitamin D3, and 1,25-(OH)2D3. The vIL-10 could elicit a host immune response 
capable of neutralizing or depleting IL-10, or the vIL-10 could compete with IL-10 
but fail to perform an essential IL-10 function. In either case, the lack of sunlight 
exposure and the herpes virus infection might synergize to induce a defect in IL-10-
producing regulatory lymphocyte function that undermines self-tolerance mechanisms 
and enables a pathogenic autoimmune response to neural proteins. 
 
2.4.1. Immunologic Factors 
 
 In Multiple Sclerosis, the responses mediated by the abnormal immune cells tend 
to attack the coating of the myelin sheath that is present around the nerve fibres in the 
Central Nervous System (CNS). Several researchers in the recent years were able to 
determine which particular immune cells are responsible for mounting the attack and also 
determine those factors that forces them to attack and some of the common receptors 
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(sites) present on the attacking cells, which appears to get attracted to the myelin sheath 
so as to begin the destructive process. The ongoing efforts to understand more about the 
destructive process mediated by the abnormal cells in multiple sclerosis — i.e., what 
leads to the attacks, how its starts, and how it progresses or ceases — are bringing the 
researchers quite closer to understand the etiology of this chronic disease. 
 
2.4.2. Environmental Factors 
   
 Multiple Sclerosis has been found and determined to occur in areas that are away 
from the equator more frequently. The epidemiologists or the research scientists are 
putting efforts to study different patterns of the disease. They are focusing on variations 
in the demographics (i.e., gender, age and ethnic background), geography, infectious 
causes, genetics and migration patterns so as to understand the exact cause of this 
disorder. 
 A number of studies have proved that individuals who are born in the region that 
has higher risks of developing multiple sclerosis, who later tend to migrate – or move --- 
to a region with lower risks of developing multiple sclerosis before the age of 15 years 
presumes the possibility of their new era. These data suggests that an exposure to certain 
environmental agents/ factors before puberty might predisposes an individual to develop 
the disease on later stages of their life. 
  Growing research and their outputs demonstrates that Vitamin D has a crucial 
role in the development of this disease. Individuals who grow u in the regions closer to 
the equator are exposed to more sunlight in a year due to which, they tend to have greater 
levels of Vitamin D in them as it is naturally produced in the body upon exposure to sun. 
This particular phenomenon is thought to support the functioning of the immune system 
and it might aid in protecting them against the immune- mediated diseases such as 
Multiple Sclerosis. The most possible relationship between the exposure to sunlight and 
multiple sclerosis are being currently studied in different research labs. 
 Other evidences suggests that smoking might also play a key role in the 
development of MS as smoking increases an individuals’ risks of acquiring the disease 
and is mostly associated with severe forms of such diseases with a rapid progression. 
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However, the evidences also suggest that smoking cessation either prior to the onset or 
post the onset of MS – can slow down the progression of disability.  
  The multiple sclerosis clusters – i.e., the insight that huge number of MS cases 
have been reported in a specific time period in a particular region—might present clues 
to the genetic or environmental factors that might be increasing the risks of this disease. 
So far, no clear evidence has been produced from the cluster studies for the triggering or 
the causative factors or other factors associated with Multiple Sclerosis.  
 
2.4.3. Infectious Factors  
 
One is exposed to a number of bacteria, viruses and other microbes during their 
childhood, and since these viruses are well- recognized as the major causative factors of 
inflammation and demyelination, thus it is suggested that virus, bacteria or some other 
infectious agents might be responsible for the triggering factor of multiple sclerosis. More 
than a dozen of bacteria and viruses—including canine distemper, measles, Chlamydia 
pneumonia, Epstein Barr virus and human herpes virus- 6—have been investigated by 
researchers in order to determine whether or not they are involved in the MS 





2.4.4. Genetic Factors 
 
 Even though Multiple Sclerosis is not hereditary, yet having a 1st degree relative 
such as a sibling or a parent suffering from multiple sclerosis does considerably increases 
the risk of that individual to develop this disease. A number of studies have demonstrated 
that certain genes have higher prevalence in populations that have higher rates of MS. A 
number of genetic factors have been discovered in some families where more than one 
individual in the family is affected. Some experts also theorizes that development of MS 
in such families could be because of the child born has genetic factors which when 
interacts with some environmental factors, upon exposure, might trigger the immune 
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response. New sophisticated techniques has been developed now that aids in identifying 
the genes that are helping to respond to the questions related to the role of different genes 
involved in the development of MS (NMSS, 2015).  
 
2.5. Pathogenesis of Multiple Sclerosis 
 
 Multiple Sclerosis is predominantly known as an inflammatory demyelinating 
disorder; however, it also possesses a significant neurodegenerative component. The 
myelin sheaths present around the axons enables rapid and efficient promulgation of 
nerve impulses and provide axons protection (Kotter, Stadelmann, & Hartung, 2011). The 
lesions or scars predominantly occur in the white matter of the brain and very rarely in 
the grey matter. These active scars or lesions have been characterized by degeneration of 
the myelin present around the axons that is accompanied by the peri- vascular 
inflammations that involves macrophages, hypertrophic astrocytes and T- lymphocytes.  
 The anticipated major reason for these malfunctions is an individual’s defective 
immune system (Havrdova et al., 2004). At the periphery of the auto- aggressive T- cells 
are located as a major part of the immune system and these have been found to be 
responsible for triggering the defense in a living thing against the foreign cells that are 
entering into the body. Upon erroneous activation of these cells in ones’ immune system 
compels the permeate lymphocytes to pass into the CNS through the impaired blood- 
brain barrier i.e., through blood to the brain tissue, where these triggers the production of 
pro- inflammatory cytokines. These cytokines are the protein molecules that are the 
products of the immune cells, which enable communication between different cell 
systems. In the CNS, these tend to develop a multiple, irregular distribution of the 
inflammation foci that are termed as plaques (Seidl, Obenberger, 2004; Ambler 2011).  
 It is perceived that the 1st activation of the auto- aggressive T- cells is probably 
after a brain viral infection. The cytokines bears infiltrate and results in active 
inflammation that predominantly occurs in the white matter and rarely in the grey matter 
of the CNS. The second activation results in the enrichment of proliferation of specific 
cells, which when transferred to the target tissues passing the blood- brain barrier are 
broken into kindles that triggers the inflammatory mediators (Havrdova, 2009). The 
antibodies tends to bind to the macrophages along with the cytokines and thereby results 
in the degeneration of the target tissue. The inflammations foci also damage the axons 
 
13 MULTIPLE SCLEROSIS 
and the oligodendrocytes that get disturbed and later get disintegrated. The intact 
oligodendroglia has the potential to restore the axon myelination functions that describes 
the remission stage (Kappos, 2007).  
 This repeated damage results in loss of myelin sheath and its ability to regenerate 
the axons or the damaged cells and thereby induces development of atrophy in the CNS. 
The exposed demyelinated fibres then results in disrupted conductivity of the electrical 
impulses starting from the brain to the periphery and thereby leading to the functional 
failure. In the chronic phase of this disease, the underway degeneration starts 
predominately even being independent of the inflammation process (Havrdova, 2009). 
 The aggressiveness and the sensibility of this disease might be genetically 
determined. One of the possible reasons could be the organism’s ability to activate certain 
auto- aggressive cells and some inherited immune system settings. Moreover, various 
exogenous factors (smoking, vitamin D deficiency, and viral infections) are involved that 
are known to impact the pathogenesis of the disease.  
The blood- brain barrier damage usually occurs resulting in local oedema 
followed by damage due to inflammation of the myelin sheath via different mechanisms. 
The damage to the axons then results in ineffective electric impulse conductance. As a 
result, a number of issues in MS patients arise of which the major one is flow of disturbed 
Figure 2 Multiple sclerosis pathology 
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information within the neuronal networks where the damaged sites are present. However, 
the re- myelination is promoted by the inflammation itself, where the oligonucleotides 
and its related precursors play an important function (Kotter et al., 2011). Following this 
demyelination, the oligonucleotide precursor cells tend to rapidly amplify in the areas of 
demyelination and causes re- myelination (Kotter et al., 2011).  
This phenomenon extensively occurs at an early stage of the disease and is said 
to be incomplete in the progressive MS cases indicating that loss of some of the cells 
ability to remyelinate with the progression of the disease. Furthermore, even in the 
advance multiple sclerosis cases, the oliginucleotides presence have been confirmed 
indicating the potential of some regeneration. This remission process of the neurons, 
which occurs between the attacks in addition to the neuroplasticity principles, presents a 
neurobiological basis of the need for physiotherapy.  
 
 
The disease pathogenesis can be divided into two phases; where the early phase 
is characterized by the Central Nervous System (CNS) inflammation that occurs as a 
result of activated B- cells, T- cells and macrophages (Figure 2). The T- cells, 
macrophages and the antibodies that are secreted from the B- cells tends to attack the 
Figure 3 Nerve fibre ( neuron from a healthy individual and person with MS ) 
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targeted neurons thereby resulting in demyelination. Following the initial phase, this 
condition tends to gradually progress to the 2nd phase that is characterized by 
neurodegeneration and loss of axons. The disease course significantly varies between the 
patients and the symptoms presented by them, which are highly dependent upon the 
affected area of the CNS. The Figure 3 demonstrates the difference in the structure of 
the nerve fibre in a normal individual and in patients living with Multiple Sclerosis. 




2.5.1. Disease Course  
  
 Multiple sclerosis has been defined as a long- term chronic auto- immune disease, 
which usually begins with altering the relapses in the forms of sclerotic attacks and 
remissions that in most of the cases results post- 10 years to 20 years in to the secondary 
progression. The ATAC represents the acute inflammation flares, which develops s a 
result of focal or multi- factorial neurological dysfunctioning and the complications or 
Figure 4 Magnetic Resonance imaging of damaged MS brains  
 
16 MULTIPLE SCLEROSIS 
symptoms often lasts for a minimum of 24 hours. During the attacks, the patient often 
experiences symptoms that he/ she has never experienced before or had earlier but the 
symptoms had disappeared or stabilized sooner. The severity and the extent of these 
attacks to a certain extent demonstrate the activity of this complex disease; however, it is 
not a reliable indicator that is used for long- term stabilization. Additionally, 15% of these 
patients do not experience relapses. In these individuals, experts have suggested the 
neurological disabilities increases gradually.  
 This particular disease often appears in the benign or malignant forms in patients. 
The pernicious course, a patient with the malignant form of the disease might represent 
unrelated symptoms for the first few months; however, later these patients might 
experience harsh and abundant attacks. This form of disease is found to be common as 
compared to that of the benign form, where these exhibit minimal neurological deficits 
(Havrdova et al., 2006).  
Based on the frequency and pattern of the symptoms presented, the disease course 
is classified under 1 of 4 clinically defined MS types (Figure 5). The relapsing- remitting 
multiple sclerosis is one of the commonest forms of MS that accounts over 80% of the 
new diagnosis made and 55% to 60% of the total affected population. The relapsing- 
remitting MS patients often experiences relapses, 
Figure 5 Visual representation of the variable disease course in 
multiple sclerosis 
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followed by the remission periods, where little or no symptoms are present. These 
attacks tend to occur only in small numbers and disappear completely after sometime and 
are often dominated by the degenerative processes. Relapses in the MS relapsing- 
remitting stages have been associated with demyelination and focal areas of 
inflammation. 
  
Most of the relapsing- remitting MS patients will later develop the secondary- 
progressive MS. After the relapsing- remitting initial period of MS, the patients tends to 
experience loss of function progressively. This progressive disability is linked to 
irreversible damage of the axons within the CNS. It is thus possible for the relapses to 
either continue or cease with the secondary- progressive MS. At least 20% to 30% of the 
affected individuals develop the secondary- progressive MS. 
When the disease tends to progress from the onset then it is said to be a primary- 
progressive MS, where patients often experiences a stepwise or steady progression in 
disability without any symptomatic relief. It has been reported to affect approximately 
5% to 10% of the MS population. In this form, the patients tend to experience a steady 
progression of their disability since its initiation along with relapses. This form results in 
prevailing sphincter and lower spastic paraparesis limb issues and is pathogenically a 
different form of disease as it represents different histopathology, where it has little or no 
inflammation present and there is an early loss of oligodendrocytes. However, this type 
is relatively rare and affects only 5% of the patients. This form of multiple sclerosis is 
often difficult to be tackled by just using pharmacological drugs (Kaňovský, Herzig et al. 
2007).  
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 The relapsing- progressive form is the most complicated forms of all in MS, 
which often leave a permanent neurological damage without leaving a chance of any 
medications. The inflammatory activities that this form triggers in the brain tend to faster 
the progression of the disease process and this result in further deterioration during the 
disease course. If a patient has experienced this form, it won’t be surprising if the patient 
gets severely crippled over the time. However, most research studies represents that this 
does occur but occurs in a very small percentages of the patients living with multiple 
sclerosis. 
 
2.5.2 Disease Severity 
  
 The Expanded Disability Status Scale (EDSS) is one of the commonest clinical 
scales that are used to assess the neurological impairment in multiple sclerosis. The EDSS 
is known as a neurologist assessed measure, using which the neurologists assesses their 
patients based on their history and examination of their neurologic factors. Following the 
assessment, the MS patients are scored based on an ordinary scale ranging between 0 to 
10, where the score 0 indicates absence of neurological impairment while score 10 
Figure 6 Visual representation of the expanded disability status scale 
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indicates severity leading to death (Figure 6). Irrespective of the fact that these are used 
very commonly to measure the disability in MS patients, yet it has a number of 
limitations.  
  
This tool has poor reliability because it made up of a large subjective component, 
especially with respect to the assessment of the bowel/ bladder and ambulation. This can 
also result in differences in scores when examined by different neurologists. Likewise, 
the terms such as “mild”, “moderate” and “severe” used in the assessment items might 
have different meaning to different neurologists, thereby, resulting in differences in 
scoring. This tool has been also criticised as it uses a non- linear scale where the patient 
progresses faster from 1st to 5th step than between 5th to 7th step. Due to this use of non- 
liner scales, a number of cross- sectional studies shows a bimodal distribution of the 
scores. Since, this tool is used only by the neurologists, thus it is not always genuine or 
is cost- effective to be used in both research and clinical settings.  
 Even though this tool presents a comprehensive assessment of the severity of the 
disease, a number of non- specialist neurologists and other healthcare professionals, who 
have used this tool, often tends to prescribe treatments to the MS patients. Therefore, it 
is essential to develop a much simpler tool. In order to meet the needs, the Disease Step 
Scale (DSS) was developed that allowed the researchers and non- speciality healthcare 
providers to assess the severity of the disease (Table 1). The DSS and EDSS have been 
reported to be highly correlated and DSS has been suggested to have several advantages 
than the EDSS. This tool is easier to use, shows uniform distribution in patients among 
different steps and has lower inter- rate variability as compared to EDSS. Thus, DSS is 
suggested to be a useful alternative tool to EDSS in some clinical and research settings.   
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 The neuroplasticity helps some of part of the Central Nervous System (CNS) to 
change their functions and their forms as a result of external or internal changes (Brodal, 
2010a, pp. 147-156; Kleim et al., 2002; Nudo, 2003). An internal changes i.e., scars or 
lesions present in the CNS, tends to promote immediate secretion of the nerve growth 
factors, followed by cortical re- organization, axonal sprouting and alternative neuronal 
chain establishment (Comi & al., “Effect of early interferon treatment on conversion to 
definite multiple sclerosis: a randomised study, 2001). In the early phases of MS, the 
axonal sprouting is considered to be more extensive as compared to examples such as 
traumatic head injuries; however are less in the chronic phases of the disease (NMSS, 
2015). These neural mechanisms are known to augment due to active use i.e., when active 
movements are done and thus has been referred to as the “user- pressure” by activity or 
brodal dependent plasticity. The motor unit activation induces plastic alterations in the 
alpha motor neurons, the connective tissues, and the innervated muscles (Dahl, 2008). 
Thus, it this neuromuscular system is adaptable.  
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2.6. Clinical Picture 
  
 The clinical picture of this complex chronic disease majorly depends on its 
prevalence, the brain atrophy rate and on its localization of the inflammatory bearings 
in the CNS (Havrdova, 2009). Initially most research scientists focused on the sudden 
emergence of the focal neurological symptoms. This particular condition is described 
as a clinically isolated syndrome, which is manifested clinical symptoms onset that 
correspond the demyelinated events with positive lesions visible upon doing a brain 
MRI and positive outcomes seen in the cerebrospinal fluids. Approximately, 85% of 
the MS patients results in clinical multiple sclerosis (Mares, 2012). In multiple 
sclerosis, the neurological symptoms usually occur with a multi- focal distribution in 
the spinal cord and in the brain’s white matter and that keeps on progressing over the 
time. The biggest issue of this disease is the damage that occurs in the white matter 
that is present along both the lateral brain stem ventricles and optical nerves of the 
spinal cord (Seidl, Obenberger, 2004). 
 
The clinical signs comprises of the following: 
 
First Symptoms of the Cranial Nerves 
 The symptoms might vary from patient- to- patient as the complex disease is 
associated with a multitude of symptoms. It is dependent upon the type of sub- 
systems that are affected and on the individuals’ with pre-morbid condition. Most 
patients exhibit clinical manifestations that comprises of sensory, motor, autonomic 
and visual systems (Compston & Coles, 2008). However, there are few symptoms 
that are commonly found in all MS patients.  
 Fatigue 
Fatigues are a condition where the patient loses physical or mental energy 
that in turn interferes with the patients’ daily activities. It is one of the commonest 
symptoms and is reported in almost 90% of the patients. It could be associated 
with the disease process or with non- disease specific factors such as depression 
or sleep disturbances. The pathology associated with primary fatigue is complex 
in MS patients and its mechanism is still undetermined. 
 Spastic Paraparesis Weakness in legs 
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Almost all patients during their disease progression exhibit symptoms of 
gait difficulty (spastic paraparesis or ataxic), urinary incontinence, myelopathy 
and spasticity or stiffness of the legs. These symptoms can appear all of a sudden, 
as when there is a presence of transverse myelitis or they tend to develop 
insidiously during the course of weeks.  
In case of transverse myelitis, there is a possibility of rapidly develop 
syndrome of arm or leg weakness, sensory loss, or bladder involvement along 
with changes in the cerebrospinal fluid (CSF), most probably a pleocytosis. The 
research studies that followed- up patients who had presented symptoms of 
transverse myelitis for longer period demonstrated that clinically definite multiple 
sclerosis tends to develop in approximately 25% of the patients who have normal 
MRI scan of their brain during the diagnosis and then the disease tends to progress 
and after 10 years, 67% of these patients exhibit abnormal MRI scans. In most 
cases, the transverse myelitis has been suggested to appear after the patients have 
experienced an episode of optic neuritis, which is also known as the Devic 
Syndrome that appears to be diverse from that of MS. 
 Sensory Complaints 
Patients with MS often presents Lhermitte signs that comprises of 
travelling of the electric sensation down the spine of the patient and has been 
also reported to travel into the arms and legs especially when the patient flexes 
the neck forward. However this particular symptom is not very specific to MS 
and its presence in younger patients confirms the presence of this disease.  
Most patients often presents constricting band- like paresthesias that 
are known to imitate small plaques in the spinal cord. These bands are often 
described as affecting the abdomen, arms, legs, pelvis or thorax and in cases 
these are not found then the patient is considered to be hysteric. One of four 
patients often complaints of distressing crawling- and- creeping sensation on 
their faces, which often come and go. Examination often exhibits slight 
muscle rippling around their lips, which is also known as facial myokymia. 
  
 Retrobulbular neuritis 
One of the most frequent initial symptoms of MS is the retrobulbar 
neuritis in the optic nerve. The demylination that occurs in the brains tends to 
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impact almost any part of the optic nerve due to which the patients tends to 
have impaired color perception, reduced central vision, feeling of pressure or 
pain behind the eyes that worsens the eye movements and loss of visual field. 
The inflammation in the ocular nerve might occur several time, yet there are 
little or no subjective functional defect present (Diblík, Kuthan, Glass, 2011). 
 Nystagmus 
This disability occurs in the oculomotor pathways that results in 
involuntary jerking of the eye movements, especially in the extreme eye 
positions and also exhibits inability to capture the images that are clear and 
double vision. When the nystagmus is at its initial stage or are present in 
lighter degree, the patients often fail to perceive the issues (Havrdova et al., 
2006).  
 Inter- nuclear Opthalmoplegia 
 It is one of the commonest extra- ocular disorders that are seen in MS 
patients. It occurs in approximately 40% to 76% of the patients. The 
demyelination has huge impact on the fasciculus longitudinalis medialis, 
which is a white matter tract and that transverse the majority of the brainstem. 
This is conjugate lateral gaze disorder where the affected eye presents 
adduction impairment. In this condition when one tries to gaze contra- 
laterally the effected eye tends to minimally adduct. This occurs majorly due 
the lesions present in the cerebellar or the brainstem and thereby results in 
visual fatigue, diplopia, blurred vision and oscillopsia.  Upon MRI, posterior 
fossa lesions are usually found in such patients (Diblik, 2012). A unilateral 
INO is seldom of vascular origin and it’s usually occurs as a result of stroke 
in older patients.  
 Diplopia  
The binocular diplopia usually tends to occur in MS patients due 
which they have issues of double vision. This tends to lasts in paients for days 
to weeks.  Due to damage of the nerve pathways that are responsible for eye 
movements, the eyes get misaligned and the vision messages from each eyes 
gets dis- coordinated thereby resulting in double vision (Dibik, 2012). Upon 
examination, often inter- nuclear opthalmoplegia (INO) is found that restricts 
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full adduction of one eye while abducting nystagmus results in the horizontal 
gaze, which often occurs in the other eye.  
 Facial palsy  
The facial paralysis occurs as a result of nerve damage that leads to 
loss of facial movements. In this case, the facial muscles get weakened. This 
can result either on one side or on both sides of the face. 
 Cognitive/ behavioural problems 
Most MS patients exhibit mood disorders or cognitive impairment or 
both. The most common cognitive problems comprises of concentration 
disability, easy distractibility, impaired verbal fluency, and slowing of 
psychomotor skills. The development of these issues starts either at early or 
at later stages during the disease progression process. However, it is to some 
extent very unusual as some MS patient might present symptoms of dementia 
as well. The prevalence of the depression among these patients has been 
reported to be higher as compared to other patient populations. However, it 
also often remains unrecognized or undetected in patients and thus remain 
untreated. 
 A number of studies have reported that greater that one- third of the 
MS patient population has been detected to suffer from major depressive 
symptoms. Additionally, approximately, two- thirds of these depressed MS 
patients were found to be suicidal and have been reported to be devoid of anti- 
depressant medications, which emphasizes that there is an urgent need for the 
identification of cure or interventions to treat this kind of depression in such 
patients. 
 Inco- ordination 
Ataxia has been reported to be very common among MS patients 
where some patients demonstrated symptoms of truncal ataxia that becomes 
severe due to which they are unable to sit up independently.  
 Speech 
Most patients with MS demonstrate issues with their speeches, which 
is further characterized as metered or scanning. Such patient has been seen to 
frequently use their accents on the wrong word or syllable. However, 
dysphagia has been frequently accompanied with dysarthria and thus needs to 
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be screened frequently in order to prevent such complications from occurring 
and also other complications such as aspiration pneumonia.  
 Bladder Incontinence 
Patients often exhibit urinary tract symptoms as well that eventually 
tends to develop into severe form in most MS patients. Even though these 
symptoms usually occur as a result of urinary retention issues, form of urge 
incontinence, etc. Although, the symptoms of urinary retention is less 
common, it might have serious medical consequences if remained untreated, 
such as frequent infections in the urinary tract or hydronephrosis.  
 Hemiparesis 
Even though in majority of the MS cases presenting the problem of 
hemiparesis occurs as a result of stroke, yet certain presentations appears to 
trigger the search for MS. In young patients, the hemiparesis often occurs in 
the insidious form or have a slow onset along with fluctuations that suggests 
that the patient has MS, especially when there has been already a history of 
optic neuritis or some other form of neurologic complications.  
 Paroxysmal Symptoms 
A brief or sudden episode of ataxia, dysarthria and so- called spasms 
can be detected in patients affected with MS. These spasms are also called as 
tonic seizures; however, they are often considered as a misnomer. Mostly, 
these spasms are known to comprise of painful twisting of the patients’ 
extremities, which is often elicited by hyperventilation. Experts believe that 
such paroxysmal symptoms occur from the regions where demyelination has 
occurred and where the crosstalk between the axons and the neurons takes 
place. 
 Pain 
In approximately 90% of the patient this is the commonest manifested 
complication. The most common pain syndromes can be further broadly 
distinguished into different subtypes: paroxysmal, musculoskeletal and 
neurogenic.  
 The neurogenic pain represents a characteristic tingling, numbness or 
burning sensation 
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 The prototypical paroxysmal syndrome is a kind of tic douloureux or 
trigerminal neuralgia that is presented as severe paroxysmal,, 
lancinating pain in the face. The trigerminal neuralgia or tic 
douloureux tends to occur in the young adults or it bilaterally increases 
the suspicion of multiple sclerosis in those patients.  
 The musculoskeletal pain can be primary or secondary; similar to 
hemiparesis which results in musculoskeletal pain that occurs in the 
compensating stronger side.  
2.7.  Prognosis 
 
 Multiple Sclerosis is progressive auto- immune disease, where the accumulation 
of the activity of the disease is found in most patients even after years in the form of 
cognitive and/ or physical impairment (Fisniku & al., 2008). Studied showed that even 
after follow- up for 2 consecutive years, approximately 50% of the patients living with 
clinically isolated syndrome fail to meet the diagnostic criteria set for Multiple Sclerosis 
while after 20 years these becomes more than 80% (Polman, 2006). Even though the 
majority of the patients are eventually diagnosed with MS, yet a minority of them still 
continues as clinically isolated syndrome (Comi & al.,2001; Comi & al.,2009). Since the 
modifying agents of the disease has been repeatedly proven to setback the second relapse, 
it is often suggested that the disease modifying therapy should be started right after the 
first relapse. Nevertheless, there have been evidences that indicates that some of the 
patients experiences little or no progression in their disease in the future after their first 
relapse and they thus remains clinically isolated syndrome patients even in absence of 
therapies (Jacobs, 2000; Kappos, 2007). Therefore, it is imperative to identify these 
patients or patients who experiences progressive disease activity. 
2.8. Diagnosis 
 
 It is very important to diagnose Multiple Sclerosis at an early stage. By early 
stage, experts mean the clinically isolated syndrome (CIS) and the initial months after 
being transited into definite multiple sclerosis. Since the starting point, that is, beginning 
of the disease, the disease starts damaging the neurological system and thereby resulting 
in permanent neurological deficit.  Therefore, injury to the Central Nervous System 
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(CNS) noted even before the occurrence of first clinical symptom indicates the presence 
of MS. Additionally, if it is possible to detect and identify the presence of this disease at 
an early stage then the disease progression can be controlled and the irreversible damage 
of the CNS can be restricted and thereby the related disabilities (Mares, 2012).  
 Previously, multiple sclerosis was detected based on the clinical symptoms. 
However, over the course of time, new diagnostic methods were developed such as 
examination of the cerebrospinal fluid, visual evoked response (VER) test, magnetic 
resonance imaging, etc. using which it became each to diagnose this disease. The 
McDonald criteria was developed by experts as the diagnostic criteria for this disease and 
in 2010, this criteria was updated, which allows one to detect this disease right after its 
first clinical attack i.e., when the patient disease is considered as clinically isolated 
syndrome (CIS) (Josey et al., 2012; Polman et al., 2011) (Table 2). In the relapsing 
remitting course (RR-MS), the diagnosis is done based on the verification of the 
disseminated illness over the time and localization with no other symptom explanation.  
The Primary Progressive stage is difficult to diagnose; however, this can be detect after 
1 year of the progression when positive outcomes can be expected in the MRI scans, VER 
tests and cerebrospinal fluid (Josey et al., 2012). The degree of disability and the 
neurological impairments can be measured by using clinical recording systems. The most 
commonly used tool for measurement is the Expanded Disability Status Scale (EDSS) 
(Kurtzke, 1983) (as discussed above). A score “4” in EDSS is defined as the restrictions 
to walk more than 500 meters while score= 6 indicates the dependency on a crutch to 
walk even 100 meters, and score= 7 demonstrated the permanent dependency on a 
wheelchair for ambulation (Kurtzke, 1983). In patients with untreated MS, 
approximately, 50% experiences restriction in walking distance after 8 years to 10 years, 
dependency on walking aid even for walking 100 meters after 20 years, and the 
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2.9. Treatment 
 
 The treatment to cure multiple sclerosis in patients is yet to be determined; 
however, the disease is considerably impacted by using immunosuppressive and 
immunomodulatory therapies. These therapies aims at influencing the patient’s immune 
system; however, it is important that the therapy is started in a timely manner i.e., it is 
best to start when clinically isolated syndrome is detected so as to prevent the occurrence 
of the irreversible CNS damage. The therapeutic approach differs in different stages of 
the disease such that is when the neurological symptoms are worsening over the time the 
treat is aimed at suppressing the acute inflammation while the long- term treatment aims 
at reducing the total number of attacks and its frequency during the disease progression. 
The symptomatic treatments majorly impact the number of symptoms during different 
stages of the disease (Havrdova et al., 2006).  
 Patients are usually treated at the specialized neurological Multiple Sclerosis 
centers where the access for treating this disorder is comprehensive, which not only 
includes pharmacological remedies but also has rehabilitation therapies and 
physiotherapies. The patients in such centers are also provided with counseling sessions 
so as to help them and convince them to adhere to their treatment regimen in order to lead 
a healthy life style (Preiningerova, 2012). 
 
2.9.1. Pharmacological treatment 
 
 The treatment for acute relapse usually includes intravenous administrations of 
high doses of corticosteroids such as methylpredisolone without any alternative oral 
therapy.  This drug can be administered even at an out- patient basis in some of the cases 
depending on the severity of the disease. However, if the patient also suffers from other 
MS- associated diseases such as diabetes, coronary artery disease, etc. for which they 
needs to be hospitalize usually experiences some major side- effects upon administration 
of corticosteroids. Thus, to prevent these effects, the patients are often preventively 
detained. At the end of the therapy, it also becomes important to prevent the rebounds, 
flares, inflammations, etc. due to withdrawal of corticosteroids. Thus, the expert usually 
reduces the doses slowly for these patients until withdrawal. If the therapy is stopped 
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unappreciatively then the clinical symptoms tends to persists over three weeks and one 
can experience series of plasmapheresis (Mareš, 2012; Meluzínová, 2010).  
 The long- term treatment on the other hand aids in reducing the inflammatory 
activity, which in turn reduces the number and intensity of these relapses and slows down 
the progression of the disease in patients. Patients who experience the relapsing- remittent 
waveform and exhibits high disease activity are usually treated with drugs as first choice. 
These patients, however, needs to comply with the indicative drug criteria of the drug of 
choice. These criteria include diagnosis of the relapsing forms of multiple sclerosis based 
on the McDonald criteria. The drug of choice belongs to the group of immunomodulatory 
drugs that modifies the usual course of the disease, which usually comprises the 
interferon beta (such as Avonex, Rebif, and Extavia Betaferon), glatiramer acetate (i.e., 
copaxone) and disease modifying drugs (DMD) (Table 3). These different groups of 
drugs usually have different mechanisms of actions; however, both the drugs aids in 
reducing the number of relapses. The medicament administration is usually in the form 
of injection or infusion. In cases, where the patients do not meet the diagnostic criteria 
for the use of these drugs of first choice or if they hate it being administered intravenously 
then they are administered with drugs such as immunosuppressants (i.e., azathioprine or 
metothrexate) or corticosteroids (i.e., Medrol or prednisone) orally. The glatiramer 
acetate and interferon- beta drugs were approved by the FDA to clinically treat the 
patients with clinically isolated syndrome (Mares, 2012). 
 
 The second- line drugs are other alternative methods to treat patients with MS. 
These drugs are usually used when the treatment of these patients using the first drug of 
choice fails or is ineffective.  However, there are a number of disadvantages of using 
Table 3 Side effects of the interferon- beta agents used to treat MS 
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second- line drugs. These drugs are known to increase the risks of side- effects in patients 
as it includes administration of intravenous immunoglobulins, which is a concentrated 
antibody isolated from the healthy donors. These are used to inhibit the formation of the 
pathologic antibodies in the patients’ body, which are known to damage the CNS. 
Another alternative drug is the Fingolimod that has the ability to hold the leukocytes and 
the nodes and can thus effectively prevent them from entering the CNS. These 
medications can be administered orally. The second option of these drugs usually 
involves cyclophosphamide and corticosteroids such as cytostatics (Havrdova et al., 
2012). 
 In the recent years, a new drug was discovered, which was “a tested monoclonal 
antibody” commonly known as the natalizumab (also known as tysabri). This is one of 
the first biological treatments discovered to treat multiple sclerosis and patients who are 
at the relapsing- remittent MS stage where the disease activity is considerably high. 
According to the available evidences, this drug is considered to be twice the efficiency 
of the already existing drugs of first choice; however, these have a significant risk of 
developing adverse effects (Mares, 2012).  
 The symptomatic treatment usually focuses on the impacts of the disease 
symptoms that the patient experiences, irrespective of the stage of MS the patient are in. 
One of the most common complications in MS patients is increased muscle tone or 
spasticity that results in movement restrictions, pain or convulsions. Spasticity is also 
known to affect the relaxants of the central muscles and thus can be treated with 
tizanidine, baclofen, thiocochicoside, and myolastan. If these does not work then the 
patient is subjected to the rehabilitation center. Additionally, in case if these treatments 
fail or the doses of baclofen are considerably low then baclofen pump can be introduced 
under the skin of the abdomen near the region of lumbar vertebra 3 and 4  to the patients. 
This allows the gradual dosing of this drug. Botulinum toxin can also be used for treating 
local spasticity (Havrdova, 2010). 
 Patients experiencing sphincter difficulties can be treated with anti- spasmodic, 
anti- cholinergics, muscle relaxants, etc.; however, experts have suggested that in such 
cases even exercises can be used to strengthen their pelvic base. Clonazepam can be used 
for treating cerebellar tremor; however this often results in drowsiness, anxiety, 
depression, etc. in patients as a side- effect. In such cases, the patients are also 
administered with anti- depressants and are often subjected to psychotherapy. 
Paresthesias type neuralgia or neurogenic pain can be effectively treated with 
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carbamazepine or gabapentin as anti- epileptics (Havrdova, 2010). Fatigues can be dealt 
with by using pharmacotherapy where drugs such as bupropion, or amantadine modafinil 
are used (Vachova et al., 2009). Fampyra (oe Ampyra) is a new drug which can be also 
used to relieve one with their symptom. This drug is known to significantly improve the 
walking speed in adult patients living with MS.  The mode of action of this drug is to 
improve the impulse conduction across the demyelinated fibre; however, this drug has 
been proven to be effective only in few patients and not all. This drug has been used as a 
registered drug in Czech Republic but is very expensive (Preiningerova, 2012).  
 
 
2.9.2 Surgical treatment 
 
For years people have been wondering if the surgical treatment is affective to cure 
the MS disease or not, just to make it simpler again, the MS disease is not cured yet.But 
what is the surgical treatment is for when the surgery can not cure the disease? Well, the 
surgical treatment only occurs when the patient really need it which is mainly “ or mostly 
known “ in two situations. When the patient have severe tremor affecting the movement 
or patient with severe spasticity when the medications fail to work on them. The surgery 
options are (Deep brain stimulation and Implantation of a drug catheter or pump) 
(Havrdova, 2010). 
Deep brain stimulation is a procedure for tremor, which is only done after the 
conservative treatment and the pharmacotherapy fail to affect on the patient or fail to treat 
the patient properly. It is implanted on an area in the brain to stimulate any severe or 
disabling tremor which occurs on the slightest movement of the limbs, The stimulation 
affects movement by altering the activity in that area of the brain, and on the safe side it 
does not destroy any brain tissue. It is mostly used on patients who have Parkinson's 
disease to stop the tremor when medications fail, deep brain stimulation usually is the last 
choice after all other options have failed to treat MS tremor. 
Implantation of a drug catheter of pump, is for patient when have severe spasticity 
and the medications did not work on resolving the problem, it is used when the patient 
have pain of suffering from severe spasticity may have catheter pump placed on the lower 
spinal area, to have some medications constantly delivered such as Baclofen (Lioresal) 
without suffering from pain when taking the medications 
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2.9.3 Occupational therapy  
 
Occupational therapy plays an important rule in improving, and adapting the 
overall condition for a patient with multiple sclerosis. By using and training the adaptive 
equipment, occupational therapy could help the patient preform every day’s functional 
with more satisfaction and maintain self-independence. Occupational therapy plays an 
important rule in improving dynamic posture, and the ways of performing daily 
functional tasks, which spontaneously improves in multiple sclerosis patient. 
 A study have been applied to a 49 years old female patient who had multiple 
sclerosis disease for 9 years with no other symptoms to worry about, applying the 
evidence for intervention from the systematic reviews on MS that were conducted in 
conjunction with the American Occupational Therapy Association’s (AOTA’s) 
Evidence-Based Practice Project, to improve the individual basic life functions, and it 
came with significant improvement  
Table 4 Evaluation for a MS patient before and after OT 
Assessment  Evaluation  Final evaluation  
Eating  4 6 
Bathing 3 4 
Upper body dressing 4 5 
Lower body dressing 3 5 
Toileting 3 6 
Transferring from toilet 2 5 
Bathing 4 6 
Meal preparing 3 5 
 
Scoring according to AOTA’s : 1 = total assistance, 2 = maximal assistance, 3 = moderate 
assistance, 4 = minimal assistance, 5 = supervision, 6 = modified independence, 7 = 
complete independence. 
This improvement has happened in duration of 30 days which is quite significant 
 Occupational therapy is one of the fundamental treatments which could be used 
to improve the overall status of patients suffering form Multiple sclerosis disease, in one 
month period, the patient was in better shape than she was before. Of course as any 
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therapy the accepting of the therapy would change the result of the therapy, but in this 
case it for sure was incredibly effective.  
 
2.10 Lifestyle Changes   
 
Multiple sclerosis is a threatening disorder because it can systematically 
progress into permanent disability of the patient.  This study is about a male patient 
diagnosed with multiple sclerosis.  This condition has wide-ranging effects on the 
health of a patient and it can cause depression.  Noteworthy is that following this 
infection, the patient can face health challenges such as lack of muscle control; inability 
to maintain balance, changes in his thinking capacity, and vision impairments. 
The patient diagnosed with multiple sclerosis should limit or avoid fatty foods.  The 
health care providers recommend this intervention for him because high-fat diets 
increase the risk for the condition.  The health care providers also advised the patient to 
avoid sweet foods or consume low-sugar foods to avoid accumulation of blood sugar 
levels (Wahls et al., 2018).  As a result, as opposed to his previous diet whereby the 
patient used to eat sweet foods, he must now change his diet and consume less or avoid 
sweet foods and drinks.  It is evident that the amounts of sugars contained in the food 
can to increase the level of blood sugar for this patient.  
It is evident that health care providers recommend gluten-free foods.  Since the 
diagnostic outcomes indicated that the patient tested positive for multiple sclerosis, he 
should rely on gluten-free foods.  As a result, the patient should consume much wheat, 
which is a gluten-free food.  Noteworthy is that a Swank diet developed in the 1950s is 
a common diet modification specifically for people with multiple sclerosis.  
The Swank diet is a low-fat diet developed by Dr. Roy Swank.  It contains a very small 
amount of saturated fat.  Since this would be an essential diet for the patient, the patient 
should adhere to the Swank diet should consume lean fish, vegetables, fruits, whole 
grains, and non-fat dairy products to improve in his health status (Hadgkiss et al., 
2015).  These are the most common dietary modifications that occur when an individual 
undergoes multiples sclerosis.  Dietary changes became an attractive intervention for 
several physicians due to the improvements that physicians note in patients that adhere 
to the dietary recommendations the physicians approve.    
Supervised facility-based exercise programs can guarantee this patient a broad support 
and guidance to enable him to management the symptom of multiple sclerosis.  The 
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patient should perform the exercises to help him to manage the condition and live well.  
Exercise is a behavioral therapy that expressed promising outcomes regarding the 
changes in the symptoms for patients with multiple sclerosis (Landro, 2014).  Some of 
the exercises in which this patient should participate include aerobic training, endurance 
training, aquatics, resistance training, and nontraditional workout modalities of yoga.  
The latter is now common in most health and fitness centers.  
 The patient can easily conduct an aerobic exercise because it does not require any 
sophisticated equipment.  It is also accessible because it entails some of the tasks such 
as community-based walking exercise, which the patient can perform alone or with the 
aid of a friend.  These aerobic exercises can help the patient to develop muscle and 
strength control.  This patient can also allocate in his daily schedule a time in which he 
can perform press-ups, or arm-curls, wall squats, or leg abduction as opposed to the 
previous era when he was healthy.  The patient should also perform tasks such as calf 
raises, knee extensions, and sit-to-stand to enhance effective blood circulation across 
the entire body and to remain physically fit.   
As opposed to the previous era, before the patient developed multiple sclerosis, the 
patient should now perform endurance exercises such as endurance walking around a 
certain area within the compound at least thrice per week.  Ideally, this is essential 
because it can enable the patient to maintain physical stability in which he can begin to 
walk for long or short distances (Pearson, Dieberg, & Smart, 2015).  A physician would 
also recommend aquatics exercises for the patient whereby he can play in water bodies.    
Apart from performing workouts such as yoga, the multiple sclerosis patient can also 
perform resistance training whereby the patient forces the muscle to contract against an 
external resistance to enhance tone, strength, mass, and endurance.  As opposed to the 
previous era in which the patient was healthy, the patient must allocate some time daily 
for these exercises to adhere to the recommended exercise therapy.  
Yoga is a set of physical, spiritual, and mental practices that can help multiple sclerosis 
patients to remain active and manage the symptoms of the condition.  A patient 
diagnosed with multiple sclerosis should participate in yoga training to improve his 
physical fitness and ensure that he remains physically fit (Pearson, Dieberg, & Smart, 
2015).  It is evident that the patients tend to undergo muscle weakness and with time, 
they can begin to struggle to move around.  Further, this can limit them from doing 
most tasks without assistance.  Since yoga can improve both physical, spiritual, and 
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mental wellbeing, the multiple sclerosis patient can achieve much stability when they 
adhere to the exercise therapy.  
On the same note, to improve on his body balance, the patient can conduct balance 
exercise using balanced boards and ball work.  The patient can also perform activities 
such as the salsa dancing that keep the entire body active including soothing the mind.  
Since these exercises are offering an alternative way of managing multiple sclerosis, the 
health care providers recommend that the patient should be able to access healthy living 
centers, fitness centers, conduct health walks, and attend swimming pools to improve 
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My bachelor practice took place at RHB oddělení, Nemocnice Kladno a.s. from 
16.01.2017 to 27.01.2017. 
During these two weeks I was there for 8 hours every day, in total it was 40 hours, each 
session with my patient lasts for 45 minutes to 1 hour 
I had 7 days in total with my patient, two of these days she was tired and did not want to 
do any exercise, so my practice with her were 5 days 
My clinical work placement was supervised by Bc. Tomas Modlinger. 
My patient was informed from the beginning about the examination, therapy and my 
work there, and signed the informed consent. The Ethics committee at FTVS Charles 
University, Prague approved my bachelor work at RHB oddělení, Nemocnice Kladno a.s. 
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3.2. Anamnesis (medical history) 
 
Status presents 






Communication: she can communicate with the people and physiotherapists normally  
Assistive devices: roll aid walker, and ankle foot orthosis on the right side 
 
3.2.2 subjective 
Chief complaint: Patient have multiple sclerosis, patient can not walk properly or do 
normal activities, the patient have problems mainly in the right side of her body, it’s 
harder for her to control her right side more than the left side, however she is using aid 
walker when walking or standing as she can not stand or walk without it  
 
Personal anamnesis: the beginning of the patient problems occurred in the fall of 2011. 
Around six years ago the patient had flue for four times in a very short time in between, 
then she started to have pain in her ear on her right side, slowly in the next two months “ 
in the beginning of 2012 “ she started to have hemiparesis, it was getting worse and worse, 
until she could not catch properly in the spring of 2012, after that she have been getting 
worse for the next 4 months, she couldn’t rise her right leg and she was sliding when she 
was walking, and since then, she has been getting better and worse, so basically until now 
she is not in a stable condition 
Injuries anamnesis: No past injuries. 
 
Past medical and surgical history: No past surgeries. 
 
Functional anamnesis :  
-Mobility activity  
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She has been using roll aid walker as an assistive device for her to walk, and also she is 






Table 5 activities of daily living 
Function Ability of the patient  
Bathing Patient is able to bath be herself with the 
usage of special equipment in the bath 
Dressing  She can manage dressing the upper part 
easily while struggling in wearing the 
pants and right shoe  
Oral care Patient can handle it by her self 
Toileting Patient can handle it by her self 
Transferring She can transfer from one place to another 
using the walking aid, but she can not uses 
the stairs  
Walking She can walk using the aid walker  
Climbing the stairs Not able to  
Eating She can eat by herself with no help  
Cooking It’s hard for her to handle cooking and 
working in the kitchen 
Managing medications She can manage medications and she 
aware of the medications she uses  
Using phone Able to uses her phone normally 
House work Not able to  
 
Medications, pharmacological anamnesis:  
Letrox – for thyroid  
Prestrarium – for blood pressure 
Agen – for blood pressure as well 
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An silan – muscle relaxation “ every other day “   
Allergic anamnesis: corticoids 
 
Diet: she’s not following diet plan  
 
Family anamnesis: Father died because of head stroke when she was 17 years old, mother 
is heathy, sister is healthy as well   
 
Social anamnesis:  She lives in a small apartment alone, she has been hospitalized for two 
months in the hospital  
 
Occupation anamnesis, vocation: she is not working, she has been taking money from the 
government, as she it not able to work  
 
Hobbies: working in the garden, reading books 
 
3.3. Prior rehabilitation 
 
In the spring of 2012, she used to go to massage therapy because of neck pain she used 
to have 
 
3.4. Excerpt from patient’s health care file  
 
3.5. RHB indications 
 
Doctor indicated the patient to be under physiotherapy supervision for 3 months before 
she goes back for him, and maily indications is about muscle strengthening, breathing 
pattern correction and   
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3.6. Examination by physiotherapist 
 
3.6.1 Postural examination 
 “ with roller “ 
- Postural examination :  
Posterior view :  
 
 
Figure 7 Postural examination (patient from posterior view) 
 
Aspection  
- narrow base of support  
- left ankle joint is in inversion   
- calf muscles of the right side are in atrophy 
- knee valgusity is present in both right and left sides  
- hip is elevated in left side  
- Plumb line test : 
the plumb line is between the heels, the 
right leg seemed to be closer to the plumb 
line than the left one, plumb line goes 
slightly to the left of the intergluteal line, 
trunk is shifted to the right from the plumb 
line, from her lower part of the Lumbar  and 
the shift to the right side increases as we go 
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- no scoliosis curve, the trunk is shifted to the right side, starting from 
lower Lumbar “ around L4-5” there is a shift to the right side and it’s  
increasing more as we go cranially   
- left shoulder is more elevated than the right one   
 
Lateral view : “ right side “  
 
 
Figure 8 Postural examination (patient from lateral view) right side 
 
Aspection  
- right foot is supinated and in planter flexion, while the left is in while 
left one is well positioned, with no hyper planter flexion nor supination  
- hyperextension of the right knee  
- pelvis in anteversion  
- Plumb line test :  
Slightly anterior to the lateral malleolus, on 
the axis of knee joint, passes through the 
axis of hip joint, slightly anterior to the 
bodies of the lumbar vertebrae, passes 
through the shoulder joint and slightly 
anterior to the external audiotory meatus  
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- slight rotation of the body to the left side as the left part of body of the 
patient looks visible  
- posture of the spine from this side looks good except the hypokyphotic 
in the thoracic spine 
 
Lateral view : “ left side “  
 
Figure 9 Postural examination (patient from lateral view) left side 
Aspection  
- left foot is in planter flexion, it’s also in inversion  
- knee joint is in hyperextension  
- pelvis is in  anteversion  
- rotation of the body to the left side as the right side of the body is not 
slightly visible from this side  
- there is hypolordosis of the upper part of the Lumbar spine 
- Plumb line test :  
Slightly anterior to the lateral malleolus, 
slightly posterior to the axis of knee joint, 
slightly posterior to the axis of hip joint, 
passes slightly behind the bodies of the 
lumbar vertebrae, passes behind the 
shoulder joint and the external audiotory 
meatus and the entire head  
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Anterior view 
 
Figure 10 Postural examination (patient from anterior view) 
 
- left foot is in inversion and planter flextion  
- right foot is more supinated and planter flextion  
- knees valgusity are present  
- umbilicus is slightly of shifted to the right side more than the left side 
- right breast is more depressed  
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3.6.2 Gait analysis 
 “ with the aid walker “  
 
- wide base of support when walking due to the ABD of the right hip 
that happens during the gait 
- right foot is in supination during the walking 
- the walking rhythm is non periodic  
- the length of the strides are different from one leg to another, length 
of the stride on left side is in normal while the right one is swinging 
laterally 
- foot movement is present in the left side, in proper way, heel strike, 
flat foot, heel off, toes off,  while in the right foot the movement is 
initiated from the right hip, and the foot is swinging as it is elevated 
from the hip and abducted then swings forward, and it is kind of hard 
for the patient to left it up from the ground  
- the movement of the trunk is actually obvious when the patient is 
elevating the right hip to swing her entire leg forward, due to the 
elevation of the right hip, the right side of the patient is completely 
elevated, “ the shoulder, the hand and the trunk “  
- right pelvis is elevated and it is actually initiating the movement of the 





Walking pattern of the patient is one of her essential problems, right side being affected 
more by her disease plays important role in the gait pattern of the patient. The patient 
can’t walk without the air walker, the gait of the patient is affected by weakness of the 
right side lower extremity which created compensatory movement which is created by 
right hip elevation, and that for sure affected the muscles which elevate the hip and put 
the muscles that elevate the hip in hypertone. The left side is better in walking rhythm. 
But movement in general is done slowly, the patient needs so much time to move from 
her room to the training room  
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3.6.3 Anthropometric measurement (length, circumferences) 
 
Table 6 Initial anthropometric measurement  UE 
UPPER EXTREMTITIES RIGHT (cm) LEFT (cm) 
Length of upper limbs 76 75 
Length of humerus 35 34 
Length of forearm 30 30 
Length of hands 19 19 
Circumference of upper 
hand  
35 35 
Circumference of forearm 30 30 
 
Table 7 Initial anthropometric measurement LE 
LOWER EXTREMITIES RIGHT (cm) LEFT(cm) 
Anatomical length 





Length of thigh 22 22 
Length of middle leg 41 41 
Length of foot 23 23.5 
Circumference of thigh  57.5 56.5 
Circumference of knee 43 41.5 
Circumference of calf 40 40 
Circumference of ankle 27 27 
Circumference of foot  22 22.5 
 
 
3.6.4 Goniometry  
( two-arm goniometer - finger’s goniometer )  
AROM:  
Table 8 Initial active range of motion 
Name of Joint  Right Left 
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Fingers (IP1):  
( finger’s goniometer ) 
S: 0-0-90  S: 5-0-90  
Fingers (IP2):  S: 0-0-90  S: 0-0-90  




Thumb (MCP) :  S: 0-0-70 S: 0-0-70 
Thumb (IP) :  S: 5-0-90 S: 5-0-90 






Knee joint :  S: 0-0-120 S:5-0-125 




Toes (MTP) :  
 
S: 60-0-55 S: 60-0-55 
Toes (IP)big toe :  S: 0-0-60 S: 0-0-55 
C spine :  S: 55-0-45 
Lateroflexion of C spine :  50 50 
Rotation of C spine :  55 50 
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PROM 
Table 9 Initial passive range of motion 
Name of Joint  Right Left 




















Fingers (IP1):  S: 5-0-95  S: 5-0-95  
Fingers (IP2):  S: 0-0-95  S: 0-0-95  




Thumb (MCP) :  S: 0-0-70 S: 0-0-70 
Thumb (IP) :  S: 5-0-90 S: 5-0-90 






Knee joint :  S:0-0-155 S:0-0-155 




Toes (MTP) :  S: 70-0-60 S: 70-0-60 
Toes (IP)big toe :  S: 0-0-70 S: 0-0-70 
C spine :  S: 60-0-45 
Lateroflexion of C spine :  60 55 
Rotation of C spine :  60 60 
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3.6.5 Hypermobility  
Table 10 Initial hypermobility examination 
 Left Right 
Lumber spine 
Retroflexion “ Sachse “  Grade B 
Anterioflextion “ Sachse “  Grade A 
Thoracic spine 
Rotation “ Sachse “  Grade A Grade A 
Cervical spine 
Rotation “ Sachse “  Grade A Grade A 
Metacarpal joints 
Dorsal Flexion “ Janda “  Hypermobility  Hypermobility 
Metacarpal joints 
Dorsalflexion “ Sachse “  Grade C Grade C 
Wrist joint  
Dorsal flexion“ Janda “  Hypermobility Hypermobility 
Elbow joint  
Extension  “Sachse “  Grade C Grade C 
Shoulder joint  
High cross arm“ Sachse “  Grade B Grade B 
Touch the hands behind the 
back “ Sachse “  
Grade C Grade C 
Glenohumeral joint  
Abduction  “ sachse “  Grade B Grade B 
Knee joint  
Extension “ sachse “  Grade B Grade B 
Hip joint  
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Conclusion :  
The joints of the patient is hypermobile in general, which could leads to instability of the 
joints and muscles weakness, and it is could be physiological as the patient is a woman, 
in general the patient is hypermobile which could indicate lower muscle tone 
 
3.6.6 Muscle length test 
(according to Janda or Kendall) 
 
-length of ankle flexor muscles (gastrocnemius- soleus): “ Kendall “  
 “gastrocnemius ”: R - Dorsiflex 10° “ normal “ L - Dorsiflex 10° “ normal “ 
 “ soleus ” : R – dorsiflex 20 “normal” L – dorsiflex 20 ” normal  “  
-length of hip flexor muscles : “Kendall“  
 R: Both one and two joints muscles are normal length  
 L: Both one and two joints muscles are normal length  
-length of hip adductor muscles : “ Janda “  
 R: grade 0      L: grade 0 
-length of hamstring muscles : “ Kendall “ 
 R: normal        L: normal  
-length of paravertebral muscles : “ Janda “  
 grade 0 
-length of m. quadratus lumborum : “ Janda “  
 R: grade 0  
 L: grade 0 
-length of piriformis muscles : “ Janda “  
 R: grade 0  
 L: grade 0 
-length of pectoralis major (upper and lower part) “Kendall“ 
  R: upper part – normal. Lower part – normal  
  L: upper part – slight shortness. Lower part – slight shotness  
-length of pectoralis minor : “ Kendall “  
 R: slight shortness  
 L: slight shortness 
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-length test for teres major – latissimus dorsi – rhomboid major and minor muscles : “ 
Kendall “  
 R: normal length  
 L: normal length 
-length of medial and lateral shoulder rotators : “ Kendall “  
 R: lateral shoulder rotators - normal length 
      medial shoulder rotators – normal length 
 L: lateral shoulder rotators – normal length   
     medial shoulder rotators – slight shortness   
-length of carnial part of trapezius :  “ Janda “  
 R: grade 0         L: grade 0 
-length of levator scapulae :  “ Janda “  
 R: grade 0         L: grade 0 
-length of SCM :  “ Janda “  
 R: grade 0         L: grade 0 
-length of scalene muscles :  “ Janda “  
 R: grade 0         L: grade 0  
 
3.6.7 Muscles strength test 
 “ according to Kendall “  
Table 11 Initial muscle strength test 
Name of muscle Right Left 
ADD POLLICIS 3 4 
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ABD POLIICIS LONGUS 3 4 



















PRONATOR TERES AND 
QUADRATUS 
5 4 
SUPINATOR AND BICEPS 5 3+ 
BRACHIORADIALIS 5 4+ 




DELTOID (ANTERIOR( 5 5 
DELTOID (POSTERIOR( 5 5 
DELTOID (MEDDLE( 3+ 3+ 
TERES MAJOR 5 4 
PECTORALIS MAJOR:  
“ UPPER AND LOWER “ 
5 4- 
PECTORALIS MINOR 5 4 









INFRASPINATUS 5 5 








TRAPZUS LOWER PART 4+ 3 
SERRATUS ANTERIOR 5 5 
ABD HALLUCIS 2 3+ 
EXTENSOR DIG. 
LONGUS AND BREVIS 
2 4+ 
EXTENSOR HALLUCIS 
LONGUS AND BREVIS 
3+ 5 
TIBIALIS ANTERIOR 3 4 
TIBIALIS POSTERIOR 2+ 4 
PERONEI mm: 0 4 




QUADRICEPS FEMORIS: 3- 4 
HIP FLEXORS AND 
ILLIOPSOAS 
1+ 3+ 
TENSOR FASCIA LATAE 2 3+ 




GLUTEAUS MINIMUS 2 3 
GLUTEAUS MIDEUS 2 3 
SARTURIOS 2 4 
GLUTEAUS MAXIMUS 4 3 
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3.6.8 Muscle tone palpation 
 
- M. sternocleidomastoid  
In supine position, symmetrical in the left and right side  
The muscles were in hypotone 
No pain was felt during the palpation   
- Mm. scalene 
In sitting position, was really hard to palpate the right muscles  
Muscles are in hypotone, especially the right side  
No pain was felt during the palpation  
- M.trapezius ( upper, middle,lower parts ) 
Upper part : sitting position, left is normal tone while the the right one is in hyper tone  
Middle part : prone position, symmetrical in both sides, normal tone 
Lower part : prone position, hypertonic in right and normal tone in left side 
No pain was felt during the palpation for the upper, middle, or the lower parts 
- M.deltoid (anterior, middle,posterior) 
Upper part: sittin position, the right side was more hypotone than the left one 
Middle part: sittin position, both sides were in hypotone, 
Lower part: sittin position, right side is more in hypotone than the left side  
Trigger point were palpated and the patient was uncomforted  
- M.pectorales major 
In supine positon, Hypertonic in the left side and normal tonic in the right side, trigger 
point was palpated in the incertion of the muscle on the Humerus on the left side.  
painful at the left side when the patient was doing more than 120 degree flexion, 
Pateint was not comforted while palpating the trigger point on the left side other than that 
the patient didn’t feel anypain  
- M.pectorales minor 
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Supine position, both sides where in normal tone, but trigger point was found in the left 
side near the insertion “coracoid process “ , but no pain was felt during the palpation, the 
patient was just feeling uncomfortable while touching the trigger point   
- M.serratus anterior  
In supine position, muscles where in hypontone in both sides 
No pain was felt during the movement  
- M.biceps brachii 
sitting position, symmetrical in both sides  
The muscle was in normal tone in both sides  
No pain was felt during the palpation  
- M.triceps brachii 
Prone position, symmetrical in both sides  
The muscle was in normal tone in both sides  
No pain was felt during the palpation  
- Quadratus Lumborum  
Prone position, hypertone in the right side and normal tone on the left side 
A little pain was felt by the patient while palpating the right side 
- M. rectus abdominis  
Supine position,  
Muscle was in hypotone, trigger point was palpated  
Nopain was felt during the palpation of the muscle  
- M.quadriceps femoris  
Supine position, in left side the muscle is in hypertone while hypotone in the right side,  
No pain was felt during the palpation 
- Mm.adductors  
Supine position, more tonic in the left side than the right side, left is normal tonic while 
right is hypo tonic   
No pain was felt during the palpation 
- M.tibialis anterior  
In sitting position, hypertonic muscle in the left side, normal in the right side  
No pain was felt during the palpation   
- M. fibularis longus and bervis 
In sitting position, right side is more hypotonic than the hypotonic left side,  
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No pain was felt during the palpation   
- M. supraspinatus 
In sitting position, the muscle was normal tonic in the left side and hypo in the right side 
No pain was felt during the palpation 
- M. infraspinatus  
In sitting positon position, symmetrical in both sides 
In both sides the muscles were hypotonic  
No pain was felt during the palpation 
- M. latissimus dorsi  
In prone position, symmetrical in both sides 
In both sides the muscles were hypotonic  
No pain was felt during the palpation 
- M.gluteus max 
In prone position, normal in right and hypo tone in left side  
No pain was felt during the palpation 
- M.gluteus mid 
In prone position, normal tone in left side, and hyper tone in right side 
No pain was felt during the palpation 
- Hemstrings  
In prone position, the right is a bit more hypotonic than the left one  
No pain was felt during the palpation  
- M.triceps surae 
In prone position, right muscle is in hypotone, while the left one is also in hypotone but 
it’s still better than the right one,   
no pain was felt during the palpation 
 
3.6.9 Pelvis palpation   
• height and symmetry of cristae iliacae 
left is higher  
• height and symmetry of SIPSs 
left is higher 
• height and symmetry of SIASs 
right is higher  
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Conclusion :  
Elevation of the left hip in both anterior and posterior sides and the iliac crest, resulted 
because the imbalance of the muscles around the hip, and the weakness of the right side 
muscles which will lead to depression in general of the right side of the body and mainly 
the inability of the patient to stand still and have her weight in the middle and depending 
on the left side in maintain balance 
3.6.10 Romberg Test 
 
Romberg Test I 
Test is positive  
 
Since Test I is positive, no need to proceed to next ones  
*** As for the stability, the patient have no stability by herself, she needs a support for 
standing and sitting  
 
3.6.11 Breathing pattern 
 
The breathing pattern of the patient was noticed when standing sitting and lying down 
There is maximum activation of lower thoracic breathing and minimum of abdominal 
breathing when the patient is standing and sitting 
But when the patient is lying down, she’s using both lower and upper thoracic and 
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3.6.12 Neurological Examinations  
 
Table 12 Initial neurological examination 
 Upper extremity  lower extremity  
Reflexes   The biceps brachii reflex  
Same in both sides, the 
reflex was present and it 
wasn’t either, hyper or 
hypo was just normal 
The triceps reflex 
Same in both sides, the 
reflex was present and it 
wasn’t either, hyper or 
hypo was just normal 
Finger flexors  
Same in both sides, the 
reflex was present and it 
wasn’t either, hyper or 
hypo was just normal 
The knee reflex 
No reflexes on either side   
Achilles tendon reflex   
Hypo reflex on the left side 
while no reflex on the right 
side  
Superficial sensation  Normal touch was applied 
to the patient with his eyes 
closed on his upper 
extremity 
“ anterior – lateral – medial 
and posterior sides “ both 
right and left extremity  
The patient felt them both, 
but when compared the 
right and left sides, the 
patient felt the left side 
more than the right side 
Normal touch was applied 
to the patient with his eyes 
closed on his upper 
extremity 
“ anterior – lateral – medial 
and posterior sides “ both 
right and left extremity  
The patient felt them both, 
but when compared the 
right and left sides, the 
patient felt the left side 
more than the right side 
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Deep sensation  - An item was placed in 
the patient’s hand, and 
the patient was able to 
identify it 
 
- Patient was also asked 
to identify a passive 
movement “flexion of 
small finger” which 
have been done to her 
passively with her eyes 
closed, she was able to 
identify the movement 
in both sides 
 
- Then the patient have 
been asked to do the 
same previous move-
ment which have been 
done passively in the 
other side, and the 
patient was able to do 
it correctly  
 
- An extension 
movement was done to 
the patient big toe both 
sides, and the patient 
was asked to identify 
the movement, the 
patient was able to 
identify it correctly 
- Then the patient was 
asked to do the same 
movement “ extension 
of the big toe “  on her 
other leg, she was able 
to do the movement  
correctly on the left 
side, but not very good 
on the right side, but 
that is probably 
because of muscle 
weakness on right side 
Pyramidal sign Mingazzini  
Negative both sides 
*fingers flexion right side 
Rusecky  
Negative both sides 
 
Babinski  
Negative on left side 
Positive on right side  
Chaddock 
Negative on left side 
Positive on right side  
Openheim 
Positive on left side 
Positive on right side  
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Mingazzini  
Right leg fell down after 3 
seconds 
 “ positive in right side “  
 
 
2.6.13 Examination of facia  
 
lumbar fascia caudally  
Restriction were found in both sides  
lumbar fascia cranially  
No restriction in either side  
fascia on both sides of the trunk  
No restriction in either side 
shifting of the fascia around the thorax  
No restriction in either side 
The scalp  
No restriction 
Fascia at the neck and the extremities  
No restriction  
 
2.6.14 Segmental examination  
 
Cervical spine 
No restriction in any segment in either direction  
Thoracic spine 
No restriction in any segment in either direction  
Ribs 
There were no restriction  
Lumbar spine  
There was restriction in L4 segment into flexion direction only 
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Sacroiliac joint  
No restriction in sacroiliac joint 
Upper extremity  
Left shoulder restriction is present in cranial direction  
Right and left elbows are restricted  
Lower extremity 
Restriction were found in the right knee  
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3.7. Examination’s conclusion 
 
The patient  has her main problem on the right side, she can not control it properly, there 
is weakness of the muscles on the right side, which indicates imbalance and weakness of 
the muscles, she can not maintain static position without support, her body is dropped on 
the right side, Quadratus lumborum is hypertonic and hyper active because of the gait 
pattern she has, as she has a compensatory movement created by elevating the right hip 
and swing her leg forward, and that would create imbalance on the hip area. ROM of the 
shoulder on left side indicated a problem which turned to be higher tension and trigger 
points located on her left pectoral muscles, which could be because she is generally 
weaker in her right side, so she mainly uses her left side to maintain balance and get 
support, one of the most important problems of her is the peroneal muscles and hip flexors 
of the right side, it is  mostly affected because of the right side of her is more effected 
neurologically which leaded to muscle weakness and then the compensatory movement 
of her right hip appeared and then she stopped using these muscles, the hypo-tonicity of 
the patient muscles is mainly because of the medications she started to use, and that could 
be affecting the hypermobility of the patient, weakness of muscles of her right side is 
obvious in general, patient us hypermobile, she is not suffering from any restriction of 
the joints, although she has restriction in the fascia of lumbar spine in caudal direction  
 
 
3.8. Differential balance  
 
Patient has Multiple sclerosis, affecting her mainly on the right side, lack of movement 
and exercises resulted in muscles weakness and postural problems, the right side being 
more affected by the disease created very poor walking pattern, which affected the 
muscles which pull up the whole right lower extremity, knowing what disease she has, 
the patient is also affected mentally, giving her less motivation in exercising and moving, 
the patient has many problems during my first session with her, but in my opinion she 
needs mostly the motivation, neurologically the patient does not really look well, she 
needs support when standing or sitting.  
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3.9. The goal of short - term therapeutic plan  
 
- Maintain self satisfaction and improve mental condition 
- Improve facia and blood circulation  
- Passive exercises to avoid possible contractures 
- Relax over hypertonic muscles, especially muscles around the right hip 
- Improve the fascia of the back in caudal direction  
- Increase muscle activation and strengthening the muscles which are weakened  
- Mobilize restricted joints  
- Correct and improve gait pattern 
- Improve breathing pattern 
 
3.10. Proposed therapy  
 
- Soft tissue technique to improve the fascia and prepare the patient for exercises 
- Post Isometric Relaxation “ PIR” for right Quadratus Lumborum and left Pectoral 
major  
- Stretching lumber fascia in caudal direction in both sides 
- Strengthening hip flexors muscles with active and passive movements, hip 
flexors, hip ABD and hip ADD 
- Facilitate Peronei mm. in the right side  
- Mobilization techniques involved in Lumber spine, left shoulder joint, knee 
joints, and the hand precisely unspecific mobilization for the hand 
- Gait training, with walker aid 
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3.11 Goals of long-term therapeutic plan 
 
- Maintain and increase ROM of the lower extremities and upper extremities and 
mainly the right side of the patient  
- Correct gait and walking pattern, and start training on climbing and going down 
of the stairs  
- Improve breathing pattern of the patient in standing and sitting positon, by 
activating the abdominal muscles  
- Improve sensomotoric feeling 
- Increase postural stability and increase muscles strength of whole body and 
mainly right side by doing neuromuscular stimulation exercises  
- Decrease the progression of the disease  
 
3.12 Therapy proposal 
 
- Passive movement to avoid contractures, maintain and increase ROM of upper 
and lower extremities  
- Isometric and isotonic exercises to strengthening the weakened muscles 
- Facilitation of Peronei mm., strengthening muscles involved in walking 
- Strengthening the muscles of abdomen, improve breathing pattern, and activate 
muscles involved in breathing 
- Sensorimotoric exercises to improve sensomotoric feeling 
- General and conditional exercises to strengthening the whole body, which will 
help in decrease the progression of the disease 
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3.13 Day by day therapy 
 
Day 1 : 19.01.2017 
Subjectively : 
Patient was not feeling good because of some personal and emotional issues she was 
devastated 
Objectively :  
Patient uses walking aid, and she wears ankle foot orthosis in her right side, due to the 
drop foot  
Goal:  
- Maintain self satisfaction and improve mental condition 
- Improve facia and blood circulation  
- Unspecific mobilization of the hand  
- Passive exercises in the right leg, in hip, and knee joints 
- Release restricted fascia  
- Strengthening exercises  
- Breathing exercises to activate abdominal muscles and improve breathing pattern 
Proposed therapy :  
- Soft tissue technique to improve the fascia and prepare the patient for exercises 
- Passive exercises of the muscles in right side of the hip joint and knee joint to 
avoid possible contractures 
- Unspecific mobilization for the hand according to Lewit 
- Release fascia of lumbar spine in caudal direction 
- Strengthening the weak muscles from both sides of upper and lower extremities, 
with active, passive and also isometric contractions 
- Breathing exercises to increase muscle activation of the abdomen 
 
Implementation of the therapy :  
The patient was kind of tired because some personal problems, so the exercises was easy 
for her she didn’t want to do something too hard,  
- Started with soft tissue technique, to release fascia of the anterior, lateral and 
medial sides of the right thigh and lower right leg, from caudal to cranial 
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directions to increase the stimulation, and  improve blood circulation in according 
to Lewit 
- Unspecific mobilization to both hands were followed in both ventral and dorsal 
directions, according to Lewit 
-  Passively, the patient was lying supine, I had the patient right hip and knee flexed 
to maximum the patient could, then abducted and adducted the hip joint, done the 
repetition 5 times each, in slow movement, to keep the range of motion and avoid 
possible contraction. 
- Isometric strengthening exercises were done after that to right quadriceps femoris 
muscle 5 times repetition, while patient was supine, by placing a ball under her 
leg, asking her to press on it, with dorsiflexion of the ankle joint, and extension 
of knee joint 
- The patient then was in prone position, I asked her to actively extend and rise her 
whole leg off the treatment table, keep position for 2 seconds, then relax, she 
repeated this exercise 3 times in each side 
- After the active exercise, we asked the patient to take the position for releasing 
fascia of lower back in caudal direction while prone according to Lewit, repeated 
the same procedure 3 times in each side 
- And lastly we finished with breathing exercises for the patient while she was lying 
supine and sitting on the treatment table, to better function the abdominal muscles, 
the exercises were done while the patient in supine and sitting position and 
focusing on breathing in her abdominal part 
Subjective result :  
After therapy the patient was tired, and depressed as she feels that she does not improve 




Released of fascia of lumbar in caudal direction in both sides, activation of abdominal 
muscles while breathing are more obvious 
 Self-therapy :  
Non-were given to the patient in first day 
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Day 2 : 20.01.2017 
Subjectively : 
Patient was better than day before, but still not in very good mental condition  
Objectively :  
Patient uses walking aid, and she wears ankle foot orthosis in her right side, due to the 
drop foot, facia of lumbar spine in caudal direction were restricted again in both sides, 
activation of abdominal muscles while breathing were not visible  
Goal:  
- Improve facia and blood circulation  
- Unspecific mobilization of the hand  
- Passive exercises in the right leg, in hip, and knee joints 
- Release restricted fascia  
- Strengthening exercises 
- Mobilize restricted joints  
- Breathing exercises to activate abdominal muscles and improve breathing pattern 
Proposed therapy :  
- Soft tissue technique to improve the fascia and prepare the patient for exercises 
- Unspecific mobilization for the hand 
- Passive exercises of the muscles in right side of the hip joint and knee joint to 
avoid possible contractures 
- Strengthening the weak muscles from both sides in upper and lower extremities, 
with active, passive and also isometric contractions 
- Facilitation of Peronei mm. according to Kenny method  
- Strengthening abdominal muscles 
- Release fascia of lumbar spine in caudal direction 
- Mobilization of the Lumbar spine 
- Breathing exercises to increase muscle activation of the abdomen 
Implementation of the therapy :  
- Started with soft tissue technique, to release fascia of the anterior, lateral and 
medial sides of the right thigh and lower right leg, from caudal to cranial 
directions to increase the stimulation, and  improve blood circulation in according 
to Lewit 
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- Unspecific mobilization according to Lewit to both hands were followed in both 
directions, ventrally and dorsally  
- Passively, while the patient was lying supine, I have done maximum flexion of 
the right hip and knee, slowly, then back to the starting position, and hip adduction 
and abduction, and then again to maximum flexion, repeated the same procedure 
3 times 
- Isometric strengthening exercises for the Quadriceps femoris, by placing a small 
ball under her knee, then ask the patient to press on the ball down, raise her lower 
leg, with dorsiflexion of the foot, and then relax to the starting position “5 times” 
- Then exercises to the adductor group of the lower extremity muscles, by placing 
a medicine ball in between the patient’s knees, and asked her to press on it hold, 
repeat 3 times, and then moved the ball under her heels and asked her to roll it 
backward until 90 degrees of flexion is done on the hip and knees joints  
- Kenny method were applied to the Peronei mm. on the right side the patient was 
lying supine and I applied the technique by stretching the Peronei mm, muscle, 
doing the movement of the muscle passively with vibration during the movement, 
then gently with my hand I facilitated the muscle by touching it, and finally I 
asked the patient to do the motion actively, but she was not able to, so I had to 
give her assistance  
- We have done bridging exercise after that to strength core,” rectus abdominus, 
erector spinae, hamstrings and hip adductors”  while the patient was lying supine 
we asked her to put her  soles on the treatment table, flex her knees, elevate her 
hips and hold for few seconds, and then go back to starting position, I asked her 
to do the exercise 5 times  
- After the exercises, we asked the patient to take the position for releasing fascia 
of lower back in caudal direction while prone according to Lewit, repeated the 
same procedure 3 times in each side 
- Followed by a special technique for mobilization L4 according to Lewit, in 
anteflexion direction, in side lying position 
- And lastly we finished with breathing exercises for the patient while she was 
sitting, we have done a breathing exercise according to Dr.Weil for relaxing 
breathing knowing as 4-7-8 breathing exercise, the patient shall breath out 
through the mouth, making the whoosh sound, then breathing in quietly through 
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the nose, counting to 4, hold the breath and count to 7, and then breathing out 
completely while counting to 8, repeated the procedure 3 times  
 
Subjective result :  
Patient was in better mental and emotional condition from the day before, she have done 
more exercises than the day before, tired she was, but she was able to do the exercises I 
asked her to do better than the day before 
 
Objective result :  
Released of fascia of lumbar in caudal direction in both sides, activation of abdominal 
muscles while breathing are more obvious, and no evidence of activation of Peronei mm. 
on the right side 
 
Self-therapy : 
Isometric contraction of the right quadriceps femoris, with a small ball under her ankle, 
press on the ball, with knee extension, and ankle is dorsiflexed, hold for 3 seconds , 5 
times every 8 hours 
 
 
Day 3 :23.01.2017  
The patient was tired and she told the supervisor she would prefer some rest and not 
exercising  
 
Theoretically, what I was planning to do is  
Goal:  
- Improve facia and blood circulation  
- Relax hypertonic muscles  
- Strengthening exercises in the upper and lower extremities   
- Stability exercises  
- Correct and improve gait pattern 
Proposed therapy :  
- Soft tissue technique, to release fascia, improve blood circulation in the right leg, 
and thigh, according to Lewit 
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- PIR for the right Quadratus femoris and left Pectorals major  
- Strengthening the hip flexors, hip adductors and abductors muscles with active 
and passive exercises 
- Increase postural stability and increase muscles strength of whole body and 
mainly right side 
- Facilitation of the Peronei mm. according to Kenny method  





Day 4 : 24.01.2017 
Subjectively : 
The patient was in her best mental condition, she was feeling really good and she was 
excited for the therapy 
Objectively :  
Patient uses walking aid, and she wears ankle foot orthosis in her right side, due to the 
drop foot, facia of lumbar spine in caudal direction were restricted again in both sides, 
activation of abdominal muscles while breathing were not visible  
Goal:  
- Improve facia and blood circulation  
- Strengthening exercises in the upper and lower limbs  
- Breathing exercises  
- Improve sensomotoric stimulation 
- Increase postural stability and increase muscles strength of whole body and 
mainly right side 
 
Proposed therapy :  
- Soft tissue technique to improve the fascia and prepare the patient for exercises 
- Strengthening abdominal muscles 
- Strengthening the weak muscles from both sides of the upper and lower 
extremities, with active, passive and also isometric contractions 
- Facilitating the Peronei mm. in the right side using Kenny method technique  
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- Breathing exercises to increase muscle activation of the abdomen 
- Sensomotoric exercises to improve sensomotoric stimulation 
- Stability exercises  
 
Implementation of the therapy :  
- Started with soft tissue technique, to release fascia of the anterior, lateral and 
medial sides of the right thigh and lower right leg, from caudal to cranial 
directions to increase the stimulation, and  improve blood circulation in according 
to Lewit 
- Isometric exercises for the quadriceps femoris were done 5 times, patient was 
supine, placing a ball under her knee and ask her to press it in downward direction, 
making an extension of the knee, and dorsiflexion of the ankle joint 
- Active exercise were done after that, while the patient was lying supine we asked 
her to put a medicine ball under her legs and roll it to maintain flexion, that is to 
target the hip and knee flexors, asked the patient to repeat the exercise 7 times, in 
slow motion 
- Strengthening exercises for the upper extremities, pectoral muscles in both sides, 
asking the patient who have her hand 90 flexed in shoulder, extended elbow, to 
abduct both shoulders together while holding a rubber band in both her hands  
- Then she was asked to again so same exercise but instead of abducting both 
shoulders together, she had to abduct one and stand still the other shoulder, so it 
will have an isometric contraction 
- Kenny method were applied to the Peronei mm. on the right side the patient was 
lying supine and I applied the technique by stretching the Peronei mm, muscle, 
doing the movement of the muscle passively with vibration during the movement, 
then gently with my hand I facilitated the muscle by touching it, and finally I 
asked the patient to do the motion actively, but she was not able to, so I had to 
give her assistance  
- We have done bridging exercise after that to strength core,” rectus abdominus, 
erector spinae, hamstrings and hip adductors”  while the patient was lying supine 
we asked her to put her s soles on the treatment table, flex her knees, elevate her 
hips and hold for few seconds, and then go back to starting position, I asked her 
to do the exercise 5 times  
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- Long foot exercise was done to the patient on both sides, while patient was sitting 
I have done it passively 4 times, then 4 times the patient have done it with my 
assistance, and then she has done it by herself on the left side, not on the right side 
as the exercise was done to both sides, so I had to help her while she was doing it 
on the right foot 
- Stability increasing exercises the patient was asked to do, one was asking the 
patient to sit with no back support neither hands support, the patient was hardly 
able to do it by herself, we asked her to hold until she is not able to, that lasted 
around 15 seconds, the second exercise was by asking her to stand up, hold a bar 
which is into the wall, lower one hand and hold standing position with the support 
of one hand only, in both sides she did it, better stability was when she was 
holding the bar with her right hand while the left one was lowered 
 
Subjective result :  
Patient was tired but satisfied and really happy as she have done so much work on this 
day, she was feeling relieved after we finished the therapy session 
Objective result :  
Higher flexion in hip joint right side is obvious, relaxed quadratus lumborum muscle  
Self-therapy : 
Same exercises she was given last session 
 
Day 5 : 25.01.2017 
Subjectively : 
The patient was in good mental condition, she was feeling good and a bit tired from last 
day exercises   
Objectively :  
Patient uses walking aid, and she wears ankle foot orthosis in her right side, due to the 
drop foot, facia of lumbar spine in caudal direction were free in both sides, activation of 
abdominal muscles while breathing are visible  
Goal:  
- Improve facia and blood circulation  
- Strengthening exercises in the upper and lower limbs  
- Relax hypertonic muscles 
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- Mobilization of restricted joints  
- Increase postural stability and increase muscles strength of whole body and 
mainly right side 
- Breathing exercises to activate abdominal muscles and improve breathing pattern 
 
Proposed therapy : 
- Soft tissue technique to improve the fascia and prepare the patient for exercises 
- Strengthening the weak muscles from both sides of upper and lower extremities, 
with active, passive and also isometric contractions 
- Facilitating the Peronei mm. in the right side using Kenny method technique  
- PIR technique for left pectoralis major muscle and right quadratus lumborum 
muscle  
- Mobilization of Lumbar spine in ante-flexion direction 
- Stability exercises  
- Breathing exercises to increase muscle activation of the abdomen 
 
Implementation of the therapy :  
- Started with soft tissue technique, to release fascia of the anterior, lateral and 
medial sides of the right thigh and lower right leg, from caudal to cranial 
directions to increase the stimulation, and  improve blood circulation in according 
to Lewit 
- Isometric exercises for the quadriceps femoris were done 5 times, patient was 
supine, placing a ball under her knee and ask her to press it in downward direction, 
making an extension of the knee, and dorsiflexion of the ankle joint 
- Active exercise were done after that, while the patient was lying supine we asked 
her to put a medicine ball under her legs and roll it to maintain flexion, that is to 
target the hip and knee flexors, asked the patient to repeat the exercise 7 times, in 
slow motion 
- Isometric exercises for the ADD group by placing a ball between the patient 
knees, while the knees are 45 degrees bent, and feet are on the table, she squeeze 
the ball between her knees and hold for 4 seconds, repeat the exercise 5 times, 
- ABD group were actively trained, on both sides by asking the patient to lie on her 
side, raise her leg to the upward “ into ABD “ , and hold it for 5 seconds and then 
 
74 MULTIPLE SCLEROSIS 
let it go back, did this exercise 4 times on each side, Triceps surea of both sides 
were also exercised by asking the patient who is lying supine to press against my 
hand into planter flexion with my hand on her sole applying resistance  
- Kenny method were applied to the Peronei mm. on the right side the patient was 
lying supine and I applied the technique by stretching the Peronei mm, muscle, 
doing the movement of the muscle passively with vibration during the movement, 
then gently with my hand I facilitated the muscle by touching it, and finally I 
asked the patient to do the motion actively, but she was not able to, so I had to 
give her assistance  
- Stability increasing exercises the patient was asked to do, one was asking the 
patient to sit with no back support neither hands support, the patient was hardly 
able to it by herself, we asked her to hold until she is not able to, that lasted around 
15 seconds, the second one was by asking her to stand up, hold a bar which is into 
the wall, lower one hand and hold standing position with the support of one hand 
only, in both sides she did it, better stability was when she was holding the bar 
with her right hand while the left one was lowered 
- PIR technique according to Lewit, for hypertonic quadratus lumborum on the 
right side of the patient, 3 times repetition   
- Followed by a special technique for mobilization L4 according to Lewit, in 
anteflexion direction, in side lying position 
- And lastly we finished with breathing exercises for the patient while she was lying 
supine and sitting on the treatment table, to better function the abdominal muscles, 
the exercises were done while the patient in supine and sitting position and 
focusing on breathing in her abdominal part 
 
Subjective result :  
Patient was tired but satisfied and really happy as she have done so much work on this 
day, she was feeling relieved after we finished the therapy session 
 
Objective result :  
Released of fascia of lumbar in caudal direction in both sides, activation of abdominal 
muscles while breathing are even more obvious than the day before, higher flexion in hip 
joint right side is obvious, relaxed quadratus lumborum muscle  
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Self-therapy: 
Same as the day before, and we also asked her to do the bridge exercise once every 8 
hours, 2-3 repetitions each time  
 
Day 6 : 26.01.2017 
The patient had an appointment with the doctor and she could not do exercises because 
she will have to do some tests  
 
Theoretically, what I was planning to do is  
Goal:  
- Improve facia and blood circulation  
- Strengthening exercises in the upper and lower extremities   
- Improve sensomotoric stimulation 
- Correct and improve gait pattern 
Proposed therapy :  
- Soft tissue technique, to release fascia, improve blood circulation in the right leg, 
and thigh, according to Lewit 
- Strengthening the hip flexors, hip adductors and abductors muscles with active 
and passive exercises 
- Facilitation of the Peronei mm. according to Kenny method  
- Sensomotoric exercises to improve sensomotoric stimulation 
- Gait training, with walker aid 
Day 7 : 27.01.2017 
Subjectively : 
The patient did not want to do exercises this day, she was moody and emotional 
Objectively :  
Patient uses walking aid, and she wears ankle foot orthosis in her right side, due to the 
drop foot, facia of lumbar spine in caudal direction were free in both sides, activation of 
abdominal muscles while breathing are visible  
Goal:  
- Relax hypertonic muscles 
- Release restricted fascia 
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- Mobilize restricted joint 
 
Proposed therapy : 
- PIR technique for left pectoralis major muscle and right quadratus lumborum 
muscle  
- Release lumbar fascia in caudal direction according to Lewit 
- Unspecific mobilization of the hands according to Lewit was applied in ventral 
and dorsal directions 
- Mobilization of the Lumbar spine in ante flexion according to Lewit 
 
Implementation of the therapy :  
Because of the patient was not feeling good, and did not want to do exercises, I have just 
applied techniques for relaxing and then started with the final kinesiological examination  
- Unspecific mobilization to both hands were followed in both ventral and dorsal 
directions, according to Lewit 
- PIR technique according to Lewit, for hypertonic quadratus lumborum on the 
right side of the patient, 3 times repetition  and left Pectoralis major 
- I asked the patient to take the position for releasing fascia of lower back in caudal 
direction while prone according to Lewit, repeated the same procedure 3 times in 
each side 
- And finally, Lumbar spine mobilization into flexion for L4 was applied to the 
patient who was in side lying 




Subjective result :  
Patient was in good mental condition, not too much exercises were given to her, but she 
was relaxed after the therapy session 
 
Objective result :  
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Activation of abdominal muscles while breathing are even more obvious now than the 




Same as the day before, and we also asked her to do the bridge exercise once every 8 
hours, 2-3 repetitions each time, breathing exercises 1-2 times a day, by putting her hands 
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3.14 Final Kinesiological Examination 
 
3.14.1 Postural examination 
 “ with roller “ 
 
Postural examination :  
 
Posterior view :  
 
- Plumb line test :  
the plumb line is between the heels, the right leg seemed to be closer to the plumb line 
than the left one, plumb line goes slightly to the left of the intergluteal line, trunk is shifted 
to the right from the plumb line, from her lower part of the Lumbar  and the shift to the 
right side increases as we go cranially, until it’s goes to the left side of the head  
 
Aspection  
- narrow base of support  
- left ankle joint is in inversion   
- calf muscles of the right side are in atrophy 
- knee valgusity is present in both right and left sides  
- hip is elevated in left side  
- no scoliosis curve, the trunk is shifted to the right side, starting from 
lower Lumbar “ around L4-5” there is a shift to the right side and it’s  
increasing more as we go cranially   
- left shoulder is more elevated than the right one   
 
Lateral view : “ right side “  
 
- Plumb line test :  
Slightly anterior to the lateral malleolus, on the axis of knee joint, passes through the axis 
of hip joint, slightly anterior to the bodies of the lumbar vertebrae, passes through the 
shoulder joint and slightly anterior to the external audiotory meatus  
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Aspection  
- right foot is supinated and in planter flexion, while the left is in better 
position 
- hyperextension of the right knee  
- pelvis in anteversion  
- slight rotation of the body to the left side as the left part of body of the 
patient looks visible  
- posture of the spine from this side looks good except the hypokyphotic 
in the thoracic spine 
 
Lateral view : “ left side “  
 
- Plumb line test :  
Slightly anterior to the lateral malleolus, slightly posterior to the axis of knee joint, 
slightly posterior to the axis of hip joint, passes slightly behind the bodies of the lumbar 
vertebrae, passes behind the shoulder joint and the external audiotory meatus and the 
entire head  
 
Aspection  
- left foot is in planter flexion, it’s also in inversion  
- knee joint is in hyperextension  
- pelvis is in  anteversion  
- rotation of the body to the left side as the right side of the body is not 
slightly visible from this side  




- left foot is in inversion and planter flextion  
- right foot is more supinated and planter flextion  
- knees valgusity are present  
- umbilicus is slightly of shifted to the right side more than the left side 
- right breast is more depressed  
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- left shoulder is higher than the right one  
 
3.14.2 Gait analysis  
“ with the aid walker “  
 
- wide base of support when walking due to the ABD of the right hip 
that happens during the gait 
- the walking rhythm is non periodic  
- the length of the strides are different from one leg to another, length 
of the stride on left side is in normal while the right one is swinging 
laterally 
- foot movement is present in the left side, in proper way, heel strike, 
flat foot, heel off, toes off,  while in the right foot the movement is 
initiated from the right hip, and the foot is swinging as it is elevated 
from the hip and abducted then swings forward, and it is kind of hard 
for the patient to left it up from the ground  
- the movement of the trunk is actually obvious when the patient is 
elevating the right hip to swing her entire leg forward, due to the 
elevation of the right hip, the right side of the patient is completely 
elevated, “ the shoulder, the hand and the trunk “  
- right pelvis is elevated and it is actually initiating the movement of the 
lower extremity when the patient is walking 
 
3.14.3 Anthropometric measurement (length, circumferences) 
 
Table 13 Final anthropometric measurement UE 
UPPER EXTREMTITIES RIGHT (cm) LEFT (cm) 
Length of upper limbs 76 75 
Length of humerus 35 34 
Length of forearm 30 30 
Length of hands 19 19 
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Circumference of upper 
hand  
35 35 
Circumference of forearm 30.5 30 
 
Table 14 Final anthropometric measurement LE 
LOWER EXTREMITIES RIGHT (cm) LEFT(cm) 
Anatomical length 





Length of thigh 22 22 
Length of middle leg 41 41 
Length of foot 23 23.5 
Circumference of thigh  57.5 56.5 
Circumference of knee 43 42 
Circumference of calf 40 40 
Circumference of ankle 27 27 




3.14.4 Goniometry  
AROM:  
 
Table 15 Final active range of motion 
Name of Joint  Right Left 
Shoulder joint : 









Elbow joint :  





Wrist joint :  
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Fingers (MCP):  
( finger’s goniometer ) and 






Fingers (IP1):  
( finger’s goniometer ) 
 
S: 0-0-90  S: 5-0-90  
Fingers (IP2):  
( finger’s goniometer ) 
S: 0-0-90  S: 0-0-90  
Thumb (CMC):  






Thumb (MCP) :  
( finger’s goniometer ) 
S: 0-0-70 S: 0-0-70 
Thumb (IP) :  
( finger’s goniometer ) 
S: 5-0-90 S: 5-0-90 
Hip joint :  







Knee joint :  
( two-arm goniometer ) 
S: 0-0-120 S:0-0-125 
Ankle joint:  





Toes (MTP) :  
( finger’s goniometer ) and  
( two-arm goniometer ) 
S: 60-0-55 S: 60-0-55 
Toes (IP)big toe :  
( finger’s goniometer ) 
 
S: 0-0-60 S: 0-0-55 
C spine :  
( two-arm goniometer ) 
S: 55-0-45 
 
Lateroflexion of C spine :  
( two-arm goniometer ) 
50 50 
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Rotation of C spine :  
( two-arm goniometer ) 
55 50 
Rotation Th and L spine :  




Table 16 Final passive range of motion 
Name of Joint  Right Left 
Shoulder joint : 









Elbow joint :  





Wrist joint :  





Fingers (MCP):  
( finger’s goniometer ) and 






Fingers (IP1):  
( finger’s goniometer ) 
 
S: 5-0-95  S: 5-0-95  
Fingers (IP2):  
( finger’s goniometer ) 
S: 0-0-95  S: 0-0-95  
Thumb (CMC):  






Thumb (MCP) :  
( finger’s goniometer ) 
S: 0-0-70 S: 0-0-70 
Thumb (IP) :  
( finger’s goniometer ) 
S: 5-0-90 S: 5-0-90 
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Hip joint :  







Knee joint :  





Ankle joint:  
( two-arm goniometer ) 




Toes (MTP) :  
( finger’s goniometer ) and  
( two-arm goniometer ) 
S: 70-0-60 S: 70-0-60 
Toes (IP)big toe :  
( finger’s goniometer ) 
 
S: 0-0-70 S: 0-0-70 
C spine :  
( two-arm goniometer ) 
S: 60-0-45 
 
Lateroflexion of C spine :  
( two-arm goniometer ) 
 
60 55 
Rotation of C spine :  
( two-arm goniometer ) 
60 60 
Rotation Th and L spine :  
( two-arm goniometer ) 
45 45 
 
3.14.5 Hypermobility  
 
Table 17 Final hypermobility 
 Left Right 
Lumber spine 
Retroflexion “ Sachse “  Grade B 
Anterioflextion “ Sachse “  Grade A 
Thoracic spine 
Rotation “ Sachse “  Grade A Grade A 
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Cervical spine 
Rotation “ Sachse “  Grade A Grade A 
Metacarpal joints 
Dorsal Flexion “ Janda “  Hypermobility  Hypermobility 
Metacarpal joints 
Dorsalflexion “ Sachse “  Grade C Grade C 
Wrist joint  
Dorsal flexion“ Janda “  Hypermobility Hypermobility 
Elbow joint  
Extension  “Sachse “  Grade C Grade C 
Shoulder joint  
High cross arm“ Sachse “  Grade B Grade B 
Touch the hands behind the 
back “ Sachse “  
Grade C Grade C 
Glenohumeral joint  
Abduction  “ sachse “  Grade B Grade B 
Knee joint  
Extension “ sachse “  Grade B Grade B 
Hip joint  
Rotation “ sachse “  Grade B Grade B 
 
 
3.14.6 Muscle length test 
(according to Janda or Kendall) 
 
-length of ankle flexor muscles (gastrocnemius- soleus): “ Kendall “  
 “gastrocnemius ”: R - Dorsiflex 10° “ normal “ L - Dorsiflex 10° “ normal “ 
 “ soleus ” : R – dorsiflex 20 “normal” L – dorsiflex 20 ” normal  “  
-length of hip flexor muscles : “Kendall“  
 R: Both one and two joints muscles are normal length  
 L: Both one and two joints muscles are normal length  
-length of hip adductor muscles : “ Janda “  
 R: grade 0      L: grade 0 
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-length of hamstring muscles : “ Kendall “ 
 R: normal 
 L: normal  
-length of paravertebral muscles : “ Janda “  
 grade 0 
-length of m. quadratus lumborum : “ Janda “  
 R: grade 0  
 L: grade 0 
-length of piriformis muscles : “ Janda “  
 R: grade 0  
 L: grade 0 
-length of pectoralis major (upper and lower part) “Kendall“ 
  R: upper part – normal. Lower part – normal  
  L: upper part – slight shortness. Lower part – slight shotness  
-length of pectoralis minor : “ Kendall “  
 R: slight shortness  
 L: slight shortness 
-length test for teres major – latissimus dorsi – rhomboid major and minor muscles : “ 
Kendall “  
 R: normal length  
 L: normal length 
-length of medial and lateral shoulder rotators : “ Kendall “  
 R: lateral shoulder rotators - normal length 
      medial shoulder rotators – normal length 
 L: lateral shoulder rotators – normal length   
     medial shoulder rotators – normal length   
-length of carnial part of trapezius :  “ Janda “  
 R: grade 0         L: grade 0 
-length of levator scapulae :  “ Janda “  
 R: grade 0         L: grade 0 
-length of SCM :  “ Janda “  
 R: grade 0         L: grade 0 
-length of scalene muscles :  “ Janda “  
 R: grade 0         L: grade 0  
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3.14.7 Muscles strength test 
“ according to Kendall “  
 
Table 18 Final muscle strength test 
Name of muscle Right Left 
ADD POLLICIS 3 4 













ABD POLIICIS LONGUS 3 4 
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SUPINATOR AND BICEPS 5 3+ 
BRACHIORADIALIS 5 4+ 




DELTOID (ANTERIOR( 5 5 
DELTOID (POSTERIOR( 5 4+ 
DELTOID (MEDDLE( 4- 4 
TERES MAJOR 5 4+ 
PECTORALIS MAJOR:  
“ UPPER AND LOWER “ 
5 4+ 
PECTORALIS MINOR 5 4+ 







INFRASPINATUS 5 5 








TRAPZUS LOWER PART 4+ 3 
SERRATUS ANTERIOR 5 5 
ABD HALLUCIS 2+ 3+ 
EXTENSOR DIG. 
LONGUS AND BREVIS 
2+ 4+ 
EXTENSOR HALLUCIS 
LONGUS AND BREVIS 
3+ 5 
TIBIALIS ANTERIOR 3 4 
TIBIALIS POSTERIOR 3 4 
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Peronei mm 1 4 




QUADRICEPS FEMORIS: 3+ 4 
HIP FLEXORS AND 
ILLIOPSOAS 
2+ 4- 
TENSOR FASCIA LATAE 2 3+ 




GLUTEAUS MINIMUS 2+ 4- 
GLUTEAUS MIDEUS 2 3 
SARTURIOS 2+ 4 
GLUTEAUS MAXIMUS 4 3+ 









3.14.8 Muscle tone palpation 
 
- M. sternocleidomastoid  
In supine position, symmetrical in the left and right side  
The muscles were in hypotone 
No pain was felt during the palpation   
- Mm. scalene 
In sitting position, was really hard to palpate the right muscles  
Muscles are in hypotone, especially the right side  
No pain was felt during the palpation  
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- M.trapezius ( upper, middle,lower parts ) 
Upper part : sitting position, left is normal tone while the the right one is in hyper tone  
Middle part : prone position, symmetrical in both sides, normal tone 
Lower part : prone position, hypertonic in right and normal tone in left side 
No pain was felt during the palpation for the upper, middle, or the lower parts 
- M.deltoid (anterior, middle,posterior) 
Upper part: sittin position, the right side was more hypotone than the left one 
Middle part: sittin position, both sides were in hypotone, 
Lower part: sittin position, right side is more in hypotone than the left side  
No trigger point were palpated  
- M.pectorales major 
In supine positon, both sides where in normal tone, no trigger point were palpated 
No pain was felt during the palpation  
- M.pectorales minor 
Supine position, both sides where in normal tone, no trigger point were palpated 
No pain was felt during the palpation  
- M.serratus anterior  
In supine position, muscles where in hypontone in both sides 
No pain was felt during the movement  
- M.biceps brachii 
sitting position, the muscle was in normal tone in both sides  
No pain was felt during the palpation  
- M.triceps brachii 
Prone position, symmetrical in both sides  
The muscle was in normal tone in both sides  
No pain was felt during the palpation  
- Quadratus Lumborum  
Prone position, hypertone in the right side and normal tone on the left side 
A little pain was felt by the patient while palpating the right side 
- M. rectus abdominis  
Supine position, Muscle was in hypo tone, trigger point was palpated  
No pain was felt during the palpation of the muscle  
- M.quadriceps femoris  
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Supine position, normal tone in right side and hyper tone in left side  
No pain was felt during the palpation 
- Mm.adductors  
Supine position, more tonic in the left side than the right side, left is normal tonic while 
right is hypo tonic   
No pain was felt during the palpation 
- M.tibialis anterior  
In sitting position, hypertonic muscle in the left side, normal in the right side  
No pain was felt during the palpation   
- M. fibularis longus and bervis 
In sitting position, right side is more hypotonic than the hypotonic left side 
No pain was felt during the palpation   
- M. supraspinatus 
In sitting position, both sides the muscles were in hypo tone  
No pain was felt during the palpation 
- M. infraspinatus  
In sitting positon position, both sides the muscles were in hypo tone  
No pain was felt during the palpation 
- M. latissimus dorsi  
In prone position, both sides the muscles were in hypo tone  
No pain was felt during the palpation 
- M.gluteus max 
In prone position, normal tone in right and hypo tone in left side  
No pain was felt during the palpation 
- M.gluteus mid 
In prone position, normal tone in both sides 
No pain was felt during the palpation 
- Hemstrings  
In prone position, the right is a bit more hypotonic than the left one  
No pain was felt during the palpation  
- M.triceps surae 
In prone position, both muscles are in hypotone 
no pain was felt during the palpation 
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3.14.9 Pelvis palpation    
• height and symmetry of cristae iliacae 
left is higher  
• height and symmetry of SIPSs 
left is higher 
• height and symmetry of SIASs 
right is higher  
 
3.14.10 Romberg Test 
 
Romberg Test I 
Test is positive  
Since Test I is positive, no need to proceed to next ones  
 
3.14.11 Breathing pattern 
 
The breathing pattern of the patient was noticed when standing sitting and lying down 
The breathing is more divided into the abdominal and thoracic parts when the patient is 
sitting, standing and lying down  
 
 
3.14.12 Neurological Examinations  
 
Table 19 Final neurological examination 
 Upper extremity  lower extremity  
Reflexes   The biceps brachii reflex  
Same in both sides, the 
reflex was present and it 
wasn’t either, hyper or 
hypo was just normal 
The knee reflex 
No reflexes on either side   
Achilles tendon reflex   
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The triceps reflex 
Same in both sides, the 
reflex was present and it 
wasn’t either, hyper or 
hypo was just normal 
Finger flexors  
Same in both sides, the 
reflex was present and it 
wasn’t either, hyper or 
hypo was just normal 
Hypo reflex on the left side 
while no reflex on the right 
side  
Superficial sensation  Normal touch was applied 
to the patient with his eyes 
closed on his upper 
extremity 
“ anterior – lateral – medial 
and posterior sides “ both 
right and left extremity  
The patient felt them both, 
but when compared the 
right and left sides, the 
patient felt the left side 
more than the right side 
Normal touch was applied 
to the patient with his eyes 
closed on his upper 
extremity 
“ anterior – lateral – medial 
and posterior sides “ both 
right and left extremity  
The patient felt them both, 
but when compared the 
right and left sides, the 
patient felt the left side 
more than the right side 
Deep sensation  - An item was placed in 
the patient’s hand, and 
the patient was able to 
identify it 
 
- Patient was also asked 
to identify a passive 
movement “flexion of 
small finger” which 
have been done to her 
passively with her eyes 
- An extension 
movement was done to 
the patient big toe both 
sides, and the patient 
was asked to identify 
the movement, the 
patient was able to 
identify it correctly 
- Then the patient was 
asked to do the same 
movement “ extension 
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closed, she was able to 
identify the movement 
in both sides 
 
- Then the patient have 
been asked to do the 
same previous move-
ment which have been 
done passively in the 
other side, and the 
patient was able to do 
it correctly  
 
of the big toe “  on her 
other leg, she was able 
to do the movement  
correctly on the left 
side, but not very good 
on the right side, but 
that is probably 
because of muscle 
weakness on right side 
Pyramidal sign Mingazzini  
Negative both sides 
*fingers flexion right side 
Rusecky  
Negative both sides 
 
Babinski  
Negative on left side 
Positive on right side  
Chaddock 
Negative on left side 
Positive on right side  
Openheim 
Positive on left side 
Positive on right side  
Mingazzini  
Right leg fell down after 3 
seconds 
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3.14.13 Examination of facia  
 
lumbar fascia caudally  
No restriction in either side  
lumbar fascia cranially  
No restriction in either side  
fascia on both sides of the trunk  
No restriction in either side 
shifting of the fascia around the thorax  
No restriction in either side 
The scalp  
No restriction 
Fascia at the neck and the extremities  
No restriction  
 
3.14.14 segmental examination  
 
Cervical spine 
No restriction in any segment in either direction  
Thoracic spine 
No restriction in any segment in either direction  
Ribs 
There were no restriction  
Lumbar spine  
There was restriction in L4 segment into flexion direction only 
Sacroiliac joint  
No restriction in sacroiliac joint 
Upper extremity  
Left shoulder restriction is present in cranial direction  
Right and left elbows are restricted  
Lower extremity 
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4. Conclusion 
 
4.1 Effect of the therapy 
 
My aim of this rehabilitation will be improve the overall condition and slow the 
progression of the disease, although, in this amount of time I have seen some changes, 
regarding the muscle strength, the range of motion, the fascia in lumbar spine, the 
situation of the L4 vertebra, and the breathing pattern 
Coming to over all conclusion, I have had 5 days of therapy with my patient, there 
was noticeable changes and some improvement, so in general I can say that my therapy 
had its satisfactory effect and showed its improvement on my patient. 
I have made a table for the most noticeable changes for my patient condition from the 
first day to the last day of the therapy 
 
Table 20 Effect of the therapy 
 Initial  Final 
Muscle strength tests Pectoral muscles 
R: 5               L: 4- 
Quadriceps Femoris 
R: 3-              L: 4 
Hip Adductors 
R: 2               L: 3+ 
Hip Abductors 
R: 2               L: 3 
Gluteus muscles  
R: 4               L: 3 
Peroneal mm. 
R: 0               L: 4 
Pectoral muscles 
R: 5               L: 4+ 
Quadriceps Femoris 
R: 3+               L: 4 
Hip Adductors 
R: 2+              L: 4 
Hip Abductors 
R: 2               L: 3+ 
Gluteus muscles  
R: 4               L: 3+ 
Peroneal mm. 
R: 1               L: 4 
























Gait pattern  Walking with aid walker, 
the movement of the right 
side starts with elevation 
of the hip, with no flexion 
of the hip joint, swinging 
the elevated right leg to 
move it forward 
** Less right hip elevation 
when moving forward, 
slight hip flexion is 
present, abduction of the 
hip helps moving the leg 
forward, no extension of 
the knee  
Breathing pattern Activation of lower 
thoracic muscles and 
minimum activation of 
abdominal   
The breathing is more 
divided into the abdominal 
and thoracic parts 
Segmental examination L4 segment restricted in 
flexion direction  
The vertebra was 
mobilized  
Fascia  Restriction were found in 
both sides in the Lumbar 
fascia in caudal direction 
Restriction were released 
 
** meaning the changes are not permanent, only after PIR of Quadriceps lumborum, 
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4.2 Conclusion of the therapy  
 
My patient has Multiple sclerosis. In total I had five sessions with her, that was quite 
short time to work with a patient who has a neurological disease, I have not used any 
invasive methods during my therapy, and all the therapy plan and implementation were 
done according to what I have learned during my studies and under the supervision of 
Mr. Tomas Modlinger.  
My patient has a multiple sclerosis disease, which is not only effecting her physically, 
but also mentally, she was sensitive and emotional during my therapy with her, so the 
emotional motivation was essential during my therapy, I had to increase her motivation 
from time to time, tell her how hard she work and that she have improved from the 
previous day. Apart form that, I have used several techniques during my therapy, active, 
passive exercises, isotonic and isometric strengthening exercises, mobilization 
techniques, releasing of the fascia, exercises for breathing Kenny method, mobilization 
of lumbar spine, relaxation techniques, senosorimotoric training and stability increasing 
exercises, in a different bases, based on the patient ability on every individual day, I have 
focused on active exercises to increase muscle activity mainly, thus will increase the 
overall condition and the stability. The exercise I have done with the patient did not 
provoke any pain for the patient. 
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5. Conclusion of the work 
 
I have chosen this patient in Kladno because it was interesting case to me, 
something not common, too much work to do with, too much things to learn from, 
a lot of practice, also the patient was too kind and helpful, I learned a lot during 
these 2 weeks and I appreciate the guidance, supervising and support I got at RHB 
oddělení, Nemocnice Kladno a.s.  
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kde Vás příslušně kvalifikovaná osoba seznámila s Vaším vyšetřením a následnou 
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Místo, datum .................... 
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7.3 List of Abbreviations 
 
1. CNS = Central Nervous System  
2. cPTs = Community Physiotherapists  
3. DSS = Disease Step Scale 
4. INO = Inter- nuclear opthalmoplegia  
5. CSF = Cerebrospinal fluid 
6. EDSS = Expanded Disability Status Score 
7. CIS = Clinically isolated syndrome  
8. VER = Visual evoked response test 
9. IFN = Interferon 
10.  RR- MS = Relapsing Remitting course  
11. MS = Multiple Sclerosis 
12. MRI = Magnetic Resonance Imaging 
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